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Abstract 
Background 
Resistance against antimicrobials critically important to human medicine has been frequently 
observed in livestock and clinical settings where the selection pressure imposed by 
antimicrobial use is high. Today, it is detected in wildlife even in the absence of a direct 
selection pressure. On Penguin Island, 660 m from the coast of Western Australia, Escherichia 
coli isolated from little penguin and feral pigeon faecal samples (n = 20) was found to be 
phenotypically resistant to extended-spectrum cephalosporins and fluoroquinolones. It was 
hypothesised that the frequent observations of resistance against CIAs in this group of birds 
were a result of horizontal gene transfer. However, mobile genetic elements have historically 
been challenging to characterise using second-generation sequencing technology alone. These 
difficulties have been linked to coverage bias caused by library preparation, and to insufficient 
read length to assemble long, repetitive genomic regions. To address the limitations of read 
length, second-generation sequencing technologies were used in conjunction with third-
generation sequencing technologies to produce more contiguous assemblies while maintaining 
accuracy. To address coverage bias, the performance of the Nextera XT and Nextera Flex 
library preparation kits were evaluated to assess whether either library preparation kit was 
associated with reduced sequencing bias. 
Results 
The results of the library preparation kit comparison found that the Nextera Flex library 
preparation kit produced more even coverage than the Nextera XT kit, however tagmentation 
bias, GC content bias, de novo assembly quality and antimicrobial resistance (AMR) gene 
detection was either unchanged or poorer than Nextera XT. 
Resistance to extended-spectrum cephalosporins observed in the E. coli isolates was mediated 
mainly by blaCTX-M-15 and was shown to have circulated through the different isolates via mobile 
genetic elements such as ISEcp1, IS26 and Tn2. Resistance against fluoroquinolones occurred 
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primarily through mutations in quinolone resistance-determining regions, with only a minority 
of isolates harbouring plasmid-mediated quinolone resistance genes. Using a combination of 
second and third generation sequencing technology, a composite transposon conferring 
multidrug-resistance to macrolides, folate pathway inhibitors and aminoglycosides was found in 
varying conformations in over half of the E. coli isolates. 
Conclusions 
This study was the first to assess the Nextera Flex library preparation kit in the context of AMR 
research and found that coverage bias was markedly improved. However, this did not impact the 
practical applications of whole-genome sequencing data such as de novo assembly or AMR 
gene detection. 
Using a combination of second and third-generation sequencing technologies, this study 
established the presence of multiple mobile genetic elements conferring resistance to critically 
important antimicrobials in E. coli isolated from avian wildlife on Penguin Island, Western 
Australia. 
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1. Introduction 
Antimicrobial resistance (AMR) is one of the most serious public health concerns of the current 
era, with the rapidly increasing levels of AMR observed in hospitals, livestock, and wildlife 
threatening to create a scenario where bacterial infection once again becomes untreatable.1 The 
era of antimicrobial chemotherapy began in 1910 with the introduction of arsphenamine by 
Ehrlich, and his proposal of a ‘magic bullet’ that had selective toxicity against invading 
microorganisms without targeting host tissues.2 The announcement of the sulphonamide class of 
antimicrobial by Domagk soon followed in 1935.3 Both chemotherapeutic agents were 
superseded by the discovery and mass-purification of penicillin by Fleming, Chain and Florey.4, 
5 This launched the rapid discovery of new antimicrobial classes that targeted a wide range of 
processes unique to bacterial survival and propagation.6 Mortality from infectious disease 
declined rapidly in response to the introduction of antimicrobial chemotherapy to human 
medicine.7 The success of antimicrobials in human medicine laid the foundation for widespread 
use in animals.8 As a result, the use and misuse of antimicrobials in both humans and animals 
has accelerated the progression of AMR globally.8 
As part of the commensal gut flora, the Enterobacteriaceae family can be exposed to 
antimicrobials frequently and is therefore subject to the selection pressure that ensures the 
persistence of AMR in a bacterial population.9 The Enterobacteriaceae are a family of Gram-
negative rods that are genetically related but highly variable in their ecology, host range, and 
pathogenic potential.10 This family consists of 44 genera and 107 species, some of which 
colonise the gastrointestinal tract of mammals and form part of the commensal microbiome.10 
Certain genera such as Salmonella and Shigella, and species such as Klebsiella pneumoniae, 
Yersinia pestis, Y. enterocolitica, and some serotypes of Escherichia coli are pathogenic even 
under normal conditions, while other Enterobacteriaceae are opportunistic pathogens.8, 10 
Infection with Enterobacteriaceae can cause diarrhoeal disease and extra-intestinal infection in 
humans, as well as infectious disease in livestock, companion animals and wildlife.8, 10 E. coli 
forms part of the commensal gut flora of most mammals and is one of the dominant and most 
frequently isolated of the Enterobacteriaceae.10 They are very amenable to picking up foreign 
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DNA through horizontal gene transfer, and as a result, they are commonly used as an indicator 
species to detect AMR within a population and to track its movement through an ecosystem.8 
Despite the frequent occurrence of AMR in Enterobacteriaceae, there have been no new 
antimicrobials for the treatment of Gram-negative infections progressing to production in the 
last 40 years.11 
1.1 Critically important antimicrobials 
The World Health Organization produced a list of all classes of antimicrobials currently used in 
human medicine and categorised them based on two criteria. The first is concerned with 
whether the antimicrobial class is either the only, or one of the only available treatments for 
serious bacterial infections in humans.12 Antimicrobials that fit this criterion have an essential 
role in human medicine, and the acquisition of resistance to these therapeutics will have severe 
consequences for public health.12 The second examines whether the antimicrobial class is used 
to treat infections in humans that are caused by bacteria that either originate from non-human 
sources or can acquire resistance genes from non-human sources.12 Examples of such bacteria 
include Campylobacter spp., Enterococcus spp., Salmonella spp., E. coli, and S. aureus.12 AMR 
in these bacteria will be most readily reduced through restriction of antimicrobial use in 
animals.12 Antimicrobial classes that fulfil both criteria are categorised as critically important 
antimicrobials (CIAs).12 Of these antimicrobials, fluoroquinolones, third, fourth and fifth 
generation cephalosporins, macrolides, glycopeptides, and polymyxins are of the highest 
priority.12 Table 1 outlines the key genes that confer AMR to the CIAs in Enterobacteriaceae. 
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Table 1 Important resistance genes associated with CIAs 
Antimicrobial class AMR genes13-16 
Extended-spectrum 
cephalosporins 
blaTEM-3, blaTEM-52, blaSHV-5, blaSHV-12, blaCTX-M-1, blaCTX-M-15,  
blaCTX-M-14, blaCTX-M-27, blaOXA-2, blaOXA-10 
Carbapenems 
blaOXA-48, blaOXA-23, blaOXA-24, blaOXA-58, blaIMP, blaVIM, blaNDM, 
blaKPC 
Fluoroquinolones qnr, aac(6′)-Ib-cr, oqxAB, qepA 
Macrolides mef(A), erm(B), ere(A), ere(B), mph(A), mph(B), mph(D) 
Glycopeptides vanA, vanB, vanHAX, vanHBBXB 
Polymyxins mcr 
 
1.1.1 Extended-spectrum cephalosporins 
The bacterial cell wall has many vital functions for survival, including the maintenance of the 
integrity of cell structure and prevention of osmotic lysis.17 The structure of the cell wall differs 
between Gram-positive and Gram-negative bacteria.17 In Gram-positive bacteria, the cell wall is 
composed mainly of a thick layer of peptidoglycan that sits outside the plasma membrane.17 In 
Gram-negative bacteria, the cell wall contains an outer lipid membrane and a thin layer of 
peptidoglycan located between the plasma membrane and outer membrane.17 The cell wall is an 
essential structural component of bacterial cells that is not present in eukaryotes, therefore 
antimicrobials that target the cell wall are lethal to bacterial cells while leaving the patient’s 
own cells unharmed.17 As a result, the bacterial cell wall is a widely exploited target site for 
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antimicrobials.17  Penicillin, cephalosporin, and carbapenem β-lactams all bind to 
transpeptidases and carboxypeptidases now termed penicillin-binding proteins, causing cell 
lysis by interfering with the final stage of peptidoglycan synthesis, and therefore impairing the 
structural integrity of the cell wall.18 
β-lactamases are the main cause of resistance against penicillins and cephalosporins, 
inactivating these antimicrobials by hydrolysing the amide bond in the β-lactam ring.19, 20 The 
Ambler classification system categorises β-lactamases into four distinct molecular classes (A to 
D) based on their structural homology.19 Extended-spectrum cephalosporins are a subclass of β-
lactam antimicrobials developed in the early 1980s that were less prone to inactivation by β-
lactamases.20 They were initially effective against most β-lactamase producing bacteria, 
although resistance was observed soon after they were used therapeutically.20, 21  The enzymes 
responsible for resistance against these antimicrobials were termed extended-spectrum β-
lactamases (ESBLs), which confer resistance against the penicillins, first, second and third 
generation cephalosporins, and aztreonam.22 Carbapenems are the most recently introduced β-
lactam class and are generally reserved for the treatment of highly resistant, life-threatening 
nosocomial infections.23 With the worldwide dissemination of ESBL producing 
Enterobacteriaceae, the reliance on carbapenems led to the emergence of carbapenemases.23   
1.1.2 Fluoroquinolones 
Fluoroquinolones are a subtype of quinolone containing a fluorine atom in their chemical 
structure.14 Quinolones target gyrase and topoisomerase IV, both of which are enzymes unique 
to bacterial DNA replication.14 Topoisomerase IV is encoded by parC and parE and functions 
to decatenate newly replicated DNA, necessary for the completion of bacterial DNA synthesis.14 
Gyrase is composed of two A subunits encoded by gyrA and two B subunits encoded by gyrB, 
and functions to introduce negative supercoils into DNA through strand breakage and re-
joining.14 Maintenance of negative supercoiling is necessary for the initiation of DNA 
replication and any other processes requiring strand separation.14 Binding of a quinolone to the 
DNA-gyrase complex inhibits the re-joining stage of negative supercoiling, resulting in a 
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quinolone-DNA-gyrase complex with cleaved DNA.14 The disruption of negative supercoiling 
and decatenation inhibits DNA synthesis, and the release of the cleaved DNA from the 
quinolone-DNA-gyrase complex may trigger cell death.14 
The resistance of Enterobacteriaceae to fluoroquinolones has become increasingly common.24 
This occurs most dramatically through the accumulation of mutations in quinolone resistance-
determining regions (QRDRs) of parC, parE, gyrA, and gyrB that disable the ability of 
quinolones to bind to topoisomerase IV or gyrase.24 Plasmid-mediated quinolone resistance 
(PMQR) genes confer resistance to quinolones at a low level, increasing the amount of drug 
required to inhibit bacterial growth but not necessarily beyond a point at which the drug would 
no longer be effective in a clinical setting.24 There are four main types of plasmid-mediated 
quinolone resistance, which include expression of the Qnr protein, mutation of the 
aminoglycoside acetyltransferase aac(6’)-Ib, and the production of two different efflux pumps 
that transport fluoroquinolones out of the bacterial cell, encoded by either qepA or oqxAB.14 
Qnr, product of qnr, shields gyrase from quinolones resulting in low-level quinolone 
resistance.24 aac(6′)-Ib-cr  encodes a mutated aminoglycoside acetyltransferase that reduces 
ciprofloxacin and norfloxacin activity, which are two commonly prescribed fluoroquinolones.24 
oqxAB is a multidrug efflux pump which will remove nalidixic acid and ciprofloxacin from the 
cell, while qepA will only expel hydrophilic fluoroquinolones.24 By providing low-level 
resistance, the incidence at which mutations in QRDRs occur within a bacterial population is 
increased with the presence of PMQR genes.24 
1.1.3 Macrolides 
Macrolides that are used in human medicine include erythromycin, clarithromycin, 
azithromycin, and telithromycin.25 They prevent protein synthesis by blocking the release of the 
nascent peptide from peptidyl transferase.25 High levels of resistance to macrolides have been 
reported in E. coli through the presence of a macrolide phosphotransferase gene cluster 
consisting of mph(A), mrx, and mph(R).26 The gene mph(A) encodes a phosphotransferase that 
inactivates macrolides through phosphorylation, and mrx encodes a product of unknown 
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function.26 Both are necessary for macrolide resistance, while mph(R) is a negative regulator of 
mph(A).26 Treatment with azithromycin for enterohaemorrhagic E. coli infection is associated 
with a lower incidence of long-term carriage of the infecting agent in the host.27 As a result, the 
presence of macrolide resistance in enterohaemorrhagic E. coli strains may present a major 
public health issue.28 
1.1.4 Glycopeptides 
Glycopeptide antimicrobials interfere with peptidoglycan synthesis in Gram-positive cell walls 
by binding to an essential peptidoglycan precursor molecule called lipid II.17 They are unable to 
traverse the outer membrane in Gram-negative cell walls, and therefore have no antimicrobial 
effect on Enterobacteriaceae.29 Vancomycin and teicoplanin are the only two glycopeptide 
antimicrobials that are used in human medicine for the treatment of Gram-positive bacterial 
infection that is resistant to β-lactams.29 
1.1.5 Polymyxins 
Polymyxins cause cell lysis of Gram-negative bacteria through binding to lipopolysaccharide, 
damaging the outer lipid membrane and eventually permeating the cell membrane and causing 
cell rupture.17 Colistin and polymyxin B are the only two polymyxins used clinically.30 Even 
though they were discovered shortly after penicillin was introduced, they were never widely 
used due to their lack of specificity for bacterial cells and their ability to cause nephrotoxicity 
and neurotoxicity.30 Today, there are now multidrug-resistant Gram-negative bacteria in 
existence that are resistant to all available antimicrobials except polymyxins, and as a result they 
are re-emerging as a last resort antimicrobial.30  
1.2 Multidrug-resistance 
Terms such as multidrug-resistant (MDR), extensively drug-resistant (XDR) and pandrug-
resistant (PDR) are commonly used to describe the extent of AMR observed in healthcare 
settings.31 An international standard terminology was proposed collectively by the European 
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Centre for Disease Prevention and Control, and the Centres for Disease Control and 
Prevention.31 They defined MDR Enterobacteriaceae as AMR to at least one agent in three or 
greater antimicrobial classes in Table 2.31 XDR Enterobacteriaceae was defined as AMR to at 
least one agent in all but two or less antimicrobial classes in Table 2. PDR was defined as AMR 
to all agents in all antimicrobial classes.31 
Table 2 Antimicrobial classes and agents used to define MDR and XDR in Enterobacteriaceae adapted from 
Magiorakos et al. (2012). 
Antimicrobial category Antimicrobial agent 
Aminoglycosides Gentamycin 
Tobramycin 
Amikacin 
Netilmicin 
Anti-MRSA cephalosporins Ceftaroline 
Antipseudomonal penicillins and β-lactamase 
inhibitors 
Ticarcillin-clavulanic acid 
Piperacillin-tazobactam 
Carbapenems Ertapenem 
Imipenem 
Meropenem 
Doripenem 
1st and 2nd generation cephalosporins Cefazolin 
Cefuroxime 
3rd and 4th generation cephalosporins Cefotaxime or ceftriaxone 
Ceftazidime 
Cefepime 
Cephamycins Cefoxitin 
Cefotetan 
Fluoroquinolones Ciprofloxacin 
Folate pathway inhibitors Trimethoprim-sulphamethoxazole 
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Glycylcyclines Tigecycline 
Monobactams Aztreonam 
Penicillins Ampicillin 
Penicillins and β-lactamase inhibitors Amoxicillin-clavulanic acid 
Ampicillin-sulbactam 
Phenicols Chloramphenicol 
Phosphonic acids Fosfomycin 
Polymyxins Colistin 
Tetracyclines Tetracycline 
Doxycycline 
Minocycline 
 
1.3 Horizontal gene transfer 
Mobile genetic elements are often reported as major contributors to the global dissemination of 
antimicrobial resistant bacteria. Horizontal gene transfer describes the transmission of DNA to 
other bacterial cells through means other than cell division, occurring most frequently through 
conjugation, where a mobile genetic element is transmitted from a donor cell to a recipient cell 
using a mechanism reliant on direct cell contact.32, 33 Once a mobile genetic element has entered 
the cell, it will be lost unless it is either autonomously replicating or integrated into the bacterial 
genome.32 Such mobile genetic elements include insertion sequences (IS), transposons (Tn), 
integrons, integrative conjugative elements and plasmids.33 
1.3.1 Insertion sequences 
IS are a type of transposable element that can be loosely defined as segments of DNA less than 
2.5 kilobases long that have the capacity to integrate into a target DNA molecule.34 They 
typically carry one or two transposase (tnp) genes that provide this ability.33 IS can be grouped 
based on active site motifs in the transposase, where the most common active site motifs are 
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DDE, DEDD, and HUH.33 They can also be grouped based on transposition mechanism, 
whether this is cut-and-paste, copy-and-paste, or copy-out-paste-in.33 When transposition is cut-
and-paste, the insertion sequence is inserted directly into the recipient after being excised from 
the donor.33 When transposition is copy-and-paste, both the donor and the recipient are left with 
the insertion sequence.33 When transposition is copy-out-paste-in, the insertion sequence passes 
through a circular intermediate before being replicated into the recipient.33 
The DDE type of transposable elements are the most well-studied of the above, and contain 
terminal inverted repeats (IR) at the 5’ and 3’ ends which the protein encoded by tnp binds to 
during transposition.33, 35 During transposition, target site duplications flanking the IS are often 
created.33 IS do not carry passenger genes alone, but can move genes through the formation of 
composite transposons, defined as a region bordered by two copies of the same IS that move 
together as a single entity (Figure 1).33 IS can include a strong promoter that ensures high levels 
of expression of the captured gene in a composite transposon, while others may contain a -35 
consensus sequence that can form a hybrid promoter if positioned next to a -10 consensus 
sequence.33 
a 
 
b
 
Figure 1 Diagram of an IS (a), and a composite transposon (b) adapted from Partridge et al. (2018). 
 
IS26, a member of the IS6 family elements, has had a significant role in the spread of AMR in 
Gram-negative bacteria through the formation of composite transposons.33 This has occurred 
through both copy-and-paste and cut-and-paste transposition, although cut-and-paste 
transposition will happen at a much higher frequency than copy-and-paste transposition (Figure 
2).36 IS26 contains a -35 consensus sequence that can form a hybrid promoter.33 A plasmid or 
chromosome that already contains IS26 will more readily acquire additional IS26 along with its 
captured sequence, which can lead to the formation of large resistance islands (Figure 3).36  
tnp 
IR IR 
AMR gene IS IS 
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Figure 2 Intermolecular copy-and-paste transposition (a-c) vs. intermolecular cut-and-paste transposition (d-f) of 
IS26 adapted from Partridge et al. (2018). Both copy-and-paste and cut-and-paste transposition result in a composite 
transposon flanked with 8-bp target site duplications (c and f). Copy-and-paste transposition will insert IS26 and its 
captured sequence from a donor (b) into a recipient that does not already possess IS26 (a) and will create a composite 
transposon by producing a second copy of IS26 (c). Cut-and-paste transposition will preferentially insert IS26 and its 
captured sequence from a donor (e) into a recipient that already contains IS26 (d), forming a composite transposon by 
retaining the existing IS26 (f). 
 
ISEcp1 has also been a major contributor to the presence of AMR in Gram-negative bacteria.33 
It contains typical -35 and -10 putative promoter regions associated with Enterobacteriaceae 
and encodes a DDE type transposase that provides the ability to integrate into a target 
molecule.33, 37 ISEcp1 is often found upstream of blaCTX-M genes and may have been responsible 
for the initial mobilisation of native chromosomal β-lactamases found in Kluyvera spp. into 
plasmids commonly found in Enterobacteriaceae.38 
 
26 
26 
26 26 
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Figure 3 Preferential insertion of IS26 and captured gene, where IS26 is already present, allows for the formation of 
resistance islands. Adapted from Partridge et al. (2018). 
 
1.3.2 Transposons 
Transposons (Tn) are described as being distinct from IS in that they are larger and have 
phenotypically detectable passenger genes, although the classification between Tn and IS has 
become blurred over time, with some IS related sequences being assigned Tn numbers and vice 
versa.35 AMR genes are mainly associated with Tn3 family transposons and Tn7 like family 
transposons (summarised in Table 3).33 Tn3 family transposons have distinct 38 bp IR at both 
the 5’ and 3’ ends and contain a single, long tnpA transposase gene required for successful 
transposition. Transposition of a second Tn3 in the same vicinity as a previously existing copy 
is inhibited due to a phenomenon known as transposition immunity.33 The main difference 
26 
26 26 
26 26 26 
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between the Tn7-like family and Tn3 family transposons is the presence of multiple genes 
required for successful transposition in the former.33 
Table 3 Transposons most relevant to AMR in Gram-negative bacteria adapted from Partridge et al. (2018) 
Transposon Family AMR gene Associated AMR 
Tn1 Tn3 blaTEM β-lactam resistance 
Tn2 Tn3 blaTEM β-lactam resistance 
Tn3 Tn3 blaTEM β-lactam resistance 
Tn5393 Tn3 strAB Streptomycin resistance 
Tn21 Tn3 mer operon Mercury resistance 
Tn1721 Tn3 tet(A) Tetracycline resistance 
Tn402 Tn7-like mer operon Mercury resistance 
 
1.3.3 Integrons 
Integrons are mobile genetic elements commonly associated with Enterobacteriaceae that exist 
naturally but can form an efficient mechanism for bacteria to acquire multiple AMR genes.32, 39 
They can be present on plasmids or transposons that can then be integrated into the bacterial 
chromosome.39 Clusters of AMR genes can form within a bacterial genome through integration 
of multiple gene cassettes within the same attachment site.32 
Integrons integrate gene cassettes, which are discrete units of one complete open reading frame 
followed by an attC recombination site.32 Gene cassettes are promoterless, which puts them 
under the control of a promoter on the 5’ conserved segment (CS) of the integron.32 The genes 
that are directly downstream of the promoter are most strongly expressed, while genes further 
downstream are weakly expressed.32 Even though gene cassettes are considered mobile genetic 
elements, they do not encode the genes that are required for their mobility.32 They can exist as 
free circular molecules, but they are usually found within an integron.33 Cassettes are 
preferentially integrated at the 5’ end of the integron.32 
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The structure of an integron broadly consists of two conserved regions which flank a variable 
region.32 It contains an attachment site which is recognised by integrase and a promoter required 
for expression of the gene cassettes.32 The integrase gene (intI) is a member of the tyrosine site-
specific recombinase family and catalyses the excision and integration of the open reading 
frame (ORF).32 This is performed through strand breakage and re-joining steps, which do not 
require either DNA synthesis or ATP, distinguishing integration from transposition.32 There are 
four classes of integrons, with class 1 integrons being most relevant to AMR (Figure 4).  
Class 1 integrons contain a 5’-CS containing an integrase gene (intI1), a promoter region to 
express the inserted gene, and attC, responsible for the recombination mechanism.32 Class 1 
integrons also contain a 3’-CS containing three genes; a defective quaternary ammonium 
resistance gene qacEΔ1, sul1 encoding sulphonamide resistance, and ORF5 which has unknown 
function.32 Gene cassettes containing AMR genes can be integrated using the attC 
recombination site.32 Class 1 integrons are often carried within Tn21 and Tn402 transposons.33 
 
         
 
Figure 4 Diagram of a class 1 integron illustrating how a circularised gene cassette can be integrated into an integron 
at the attI1 site, and contribute to the formation of AMR islands. Adapted from Caratolli (2001). 
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1.3.4 Plasmids  
Plasmids often encode AMR genes, which can provide bacteria with a survival advantage in the 
presence of antimicrobials.40 They are double-stranded, circular DNA molecules that are distinct 
from the bacterial chromosome, and contain a backbone of genes necessary for plasmid 
maintenance and successful transmission.33 These include genes that allow them to replicate 
autonomously, control their copy number, ensure stable inheritance, and allow for participation 
in horizontal gene transfer through conjugation.40 Accessory genes can be added to this 
backbone that aid bacterial survival in their ecological niche.33 In an environment exposed to 
antimicrobials, these accessory genes may be AMR genes in the context of insertion sequences, 
transposons or integrons.33 Plasmids do not necessarily encode genes required for cell survival 
under normal conditions.40, 41 
Some plasmids can only be maintained in closely related species, while others can replicate in a 
diverse range of genera.33 Plasmids have an origin of replication (ori) where replication is 
initiated by the protein Rep.33 Rep is encoded by rep, usually found directly downstream of 
ori.33 Plasmids can be transferred even between kingdoms through conjugation, but they 
generally rely on the chromosomally encoded replisome to perform DNA replication.33 This 
dependence is a factor that limits the host range of a plasmid because the likelihood of a 
bacterial cell acquiring a plasmid that it does not have the replication machinery to maintain is 
high.33 Despite this, genes encoded on narrow range plasmids can still mobilise into diverse 
recipients through insertion sequences, transposons or integrons, with the plasmid acting as a 
suicide vector.33 
Plasmids need to control their copy number to ensure the stable inheritance of the plasmid 
without lowering the fitness of the host.33 Plasmids can achieve this through an antisense RNA 
complementary to the rep transcript, which is expressed in proportion to plasmid copy 
number.33 This represses expression of rep, therefore reducing the initiation of plasmid DNA 
replication.33 Other plasmids can achieve this through the number of iterons contained in the ori, 
which are short, repetitive regions of DNA that Rep binds.33 Two different plasmids can interact 
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with each other through the bound Rep proteins, inhibiting replication through a process called 
handcuffing.33 
During cell division, the replicated plasmids must be distributed between daughter cells.33 Small 
plasmids with a high copy number can be stably inherited through random segregation, however 
larger plasmids are usually maintained at a low copy number to minimise energy burden on the 
host cell.33 Progeny that do not contain the large plasmid may have higher fitness as a result, and 
therefore outcompete the daughter cells that inherit the plasmid.33 Large, low copy number 
plasmids may use compensatory mechanisms such as the multimer resolution systems, 
partitioning systems or post-segregational killing systems that contribute to their stability during 
cell division.33  
Plasmid multimers can arise through homologous recombination, though this reduces plasmid 
stability.42 The multimer resolution (res) system converts plasmid multimers into monomers 
which can be more stably inherited.42 Partitioning (par) systems consist of a centromere-like 
DNA site, centromere binding proteins, and the motor protein.33 The DNA site and centromere 
binding proteins form a complex that recruits the motor protein, which can actively move the 
plasmid to a specific location in the daughter cell, ensuring that the plasmid is inherited.33 
Postsegregational killing systems kill progeny cells that do not inherit the plasmid through a 
toxin-antitoxin system, where the plasmid encodes the antitoxin in a phenomenon known as 
plasmid addiction.33 
Conjugation 
Plasmid survival is supported not only through inheritance but also through horizontal transfer 
to unrelated bacterial cells.33 Conjugation is the transfer of a plasmid between a donor and 
recipient bacterial cell through a specialised type IV secretion system pore and DNA transfer 
replication proteins.33 The type IV secretion system pore synthesises a pilus that physically 
connects the donor and recipient cells, and the DNA transfer replication proteins process the 
plasmid DNA to be donated and couple the DNA to the pore where it can be ejected into the 
recipient cell in an energy-dependent process.33, 40 
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Plasmid classification 
The classification of plasmids relies on the concept of plasmid incompatibility.33, 41 
Incompatibility (Inc) groups are a plasmid classification scheme that is based on the stability of 
plasmids during conjugation.40 Two plasmids that belong to the same Inc group, and are 
therefore closely related, cannot exist stably in the same cell.33, 40 This occurs mainly due to the 
similarity of replication initiation systems, resulting in the two different plasmids being 
perceived as if they are two copies of the same plasmid.33 This leads to issues with copy number 
control, causing a reduced copy number of both plasmids, and plasmid instability during cell 
division.33 
Determining plasmid incompatibility is labour intensive, therefore newer plasmid classification 
schemes such as polymerase chain reaction (PCR)-based replicon typing and sequencing 
databases like PlasmidFinder have been introduced.43 These classification schemes are still 
based on Inc types, although they are assigned to a group primarily based on structural 
homology rather than plasmid incompatibility.43 There is no universal plasmid classification 
scheme that considers the entire plasmid backbone to date. However, this may develop in the 
future as the need for rapid and consistent plasmid typing in AMR research grows.33 
1.4 Presence of AMR in wildlife 
AMR is frequently reported in clinical settings and livestock as a result of the selection pressure 
that exists in these environments. However, reports of AMR in wildlife are becoming 
increasingly common even in the absence of direct antimicrobial administration to these 
animals. The presence of AMR against CIAs in wildlife constitutes a serious public health issue, 
given the importance of these antimicrobial classes to human medicine. The first report of 
ESBL-producing bacteria carried in wild animals emerged from a study performed in Europe in 
2006.44, 45 Further studies have found that the occurrence of AMR against extended-spectrum 
cephalosporins in bacteria carried by European wildlife is becoming more frequent, particularly 
in migratory birds and gulls. 
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Several studies have reported ESBL-producing bacteria carried by European gulls. The earliest 
report of ESBL-producing bacteria in gulls stemmed from a study in France that found carriage 
of blaCTX-M-15 and blaCTX-M-1 by the commensal E. coli isolated from yellow-legged gulls.46 A 
subsequent study of black-headed gulls in Sweden found that they carried ESBL producing 
bacteria resulting from blaCTX-M-14 and blaCTX-M-15 carriage, despite low levels of ESBLs in 
Swedish clinical samples.47 A more recent study of antimicrobial resistant bacteria in gulls 
throughout Europe found carriage of ESBL-producing bacteria in Spain, the Netherlands, 
England, Sweden and in low levels in Poland.48 Elsewhere in the world, ESBL-producing 
bacteria has also been detected in gulls in Alaska.49 The Alaskan study claimed that a large 
proportion of Enterobacteriaceae isolated harboured ESBL genes, where there was no ESBL 
detection in the same population of birds five years previously.49 A recent study in Australia 
found high levels of carbapenem resistance in Enterobacteriaceae isolates from silver gulls, and 
that the blaIMP-4 gene responsible was located on a variety of different plasmid Inc types.50 This 
suggests that the presence of ESBL and carbapenemase-producing bacteria in gulls has been a 
recent occurrence, but is rapidly becoming a global concern of increasing severity.  
AMR is also frequently reported in commensals colonising other migratory birds, which 
suggests that they may serve as a vector for antimicrobial-resistant bacteria that can spread 
AMR to distant ecological locations. One of the first studies observing the carriage of AMR in 
wild birds detected high levels of AMR in Canada Geese in North America, although none were 
resistant to CIAs.51 More recent studies have detected resistance against CIAs in migratory birds 
in almost every continent. Resistance against extended-spectrum cephalosporins through the 
carriage of the blaCTX-M-15 gene has been recently reported in wild birds in North Africa.52 The 
presence of PMQR genes in commensal bacteria was found in crows and ravens in North 
America, albeit at a very low frequency.53 Several different variants of blaCTX-M were found 
chromosomally integrated in E. coli isolated from wild birds in East Asia.54 A comprehensive 
study in Europe found carriage of CIA resistant Enterobacteriaceae in wild birds across eight 
different European countries.55 It was noted in this study that sampling grounds at closer 
proximity to humans generally carried more CIA resistant bacteria and that the genotypes 
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observed often mirrored what was found in nosocomial isolates in the same geographical 
locations.55  
This finding is complemented by evidence that low levels of AMR are generally reported in 
very isolated and protected areas.56, 57 A 2014 study of primates in West Africa found that 
despite the high levels of CIA resistance present in neighbouring villages, all AMR found in the 
largest tropical rainforest in West Africa was attributed to the intrinsic resistance found in the 
bacterial species studied.56 Another study conducted on a variety of species of wild animals and 
humans in a protected national park in West Africa mirrored these results.57 Both regions had 
minimal public access, and strict hygiene practices were enforced on researchers and wildlife 
trackers that required entry.56, 57 These measures have proved successful in reducing the 
presence of AMR in wildlife, even where there is a high risk of AMR gene carriage.56, 57 
While these studies have provided valuable epidemiological information about AMR carriage in 
wild animals, there are a few limitations of their work. The presence of AMR worldwide has 
been driven by a combination of successful clones, mutation under the selection pressure of 
antimicrobials and the rapid acquisition and spread of AMR genes through mobile genetic 
elements.8 The studies detecting AMR in wildlife frequently suggested that the dissemination of 
AMR was a result of horizontal gene transfer as evidenced by the lack of clonal similarity 
between the isolates identified by multilocus sequence typing (MLST). While PCR-based 
methods generally determine whether an AMR gene is present or absent without explaining the 
mechanism of how it occurred.52 Studies utilising whole-genome sequencing have been able to 
successfully determine the presence and absence of AMR genes, identify MLSTs and plasmid 
Inc types in one step. Some have even been able to provide detailed information about how 
horizontal gene transfer had occurred including the structure and function of previously 
uncharacterised mobile genetic elements. 
1.5 Whole-genome sequencing 
The use of whole-genome sequencing to study AMR provides information that traditional 
surveillance methods cannot.58 Conventional techniques such as disc diffusion testing and 
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minimum inhibitory concentration determination are commonly used to detect resistance in 
microorganisms at the phenotypic level, and genotypic resistance patterns are often 
characterised rapidly using multiplex PCR.59-61 While a combination of these methods are still 
widely used for the study of AMR, they cannot provide the same versatility or the level of detail 
that whole-genome sequencing offers. These conventional methods are able to provide an 
answer as to whether a microorganism possesses AMR genotypes, however they cannot be used 
to study the movement of antimicrobial resistant clones, determine similarity of antimicrobial 
resistant isolates to others responsible for outbreaks internationally, or track the movement of 
mobile genetic elements in different ecological niches and hosts (humans, animals and the 
environment). Whole-genome sequencing can successfully achieve all of the above, and can 
additionally provide higher resolution to outbreak investigations that previously relied on gel-
based pulse field gel electrophoresis and rapid amplification of polymorphic DNA methods. 
Even with all the advantages that whole-genome sequencing provides to AMR detection and 
surveillance, there are flaws associated with the ability of all sequencing platforms to 
characterise complete genomes accurately. The era of DNA sequencing was launched in 1977 
with the Sanger chain-termination technique.62 Sanger sequencing still has applications today, 
and is considered a gold standard for accuracy in sequencing.63 However, it was eventually 
overtaken in popularity by the low cost and high throughput nature of a novel sequencing 
technique developed by Solexa, and later acquired by Illumina, which launched the second 
generation of sequencing technologies.64 Sanger sequencing was accurate and reproducible, 
however for DNA to be sequenced it had to be cloned beforehand which introduced bias against 
unclonable genes and sequences with extreme base compositions.62 While sequencing using the 
Illumina platform did not require cloning, it required genomic DNA to be processed in vitro 
using a library preparation kit, which took genomic DNA as an input and produced amplified, 
purified DNA libraries.65 Illumina has released a variety of library preparation kits for different 
applications, with Nextera XT being widely used for small genomes.66 
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1.5.1 Library preparation 
The Nextera XT library preparation kit is the standard kit used to prepare small genomes for 
sequencing with Illumina chemistry and uses a modified transposome that has been engineered 
to fragment and insert adapters onto genomic DNA in a single reaction that Illumina has coined 
as tagmentation.67 Previous library preparation kits released by Illumina have used nebulisation 
or ultrasonication to mechanically fragment genomic DNA, followed by adapter ligation using 
3’ A-tails.68 While these methods fragment DNA randomly and in a sequence-independent 
manner, they are time-consuming and laborious, and the resultant libraries can be challenging to 
reproduce and compare between laboratories due to variation in equipment.69 Additionally, 
ultrasonication in particular can result in substantial losses of genomic DNA due to 
vaporisation.68 Using the modified transposome has the advantage of incorporating adapters and 
fragmenting DNA in a simple, five-minute reaction that can be easily reproduced between 
different laboratories.67 
The modified transposome consists of a mutant hyperactive Tn5 transposon flanked with two 
partial inverted IS50 elements required for successful transposition. The tagmentation reaction 
catalysed by the modified transposome fragments and inserts the partial IS50 element onto the 
target DNA in one step.67 The inserted DNA has several critical functions for the remaining 
steps of the library preparation protocol.66 The transposome used in the Nextera XT kit is very 
sensitive to the quantity of input DNA and requires precisely 1 ng of input DNA to fragment 
genomic DNA uniformly.66 There have been multiple reports of the Nextera XT library 
preparation kit introducing coverage bias into a sequencing run.70, 71 The most widely reported 
concerns have been linked to GC content related biases resulting from the PCR steps required 
for library amplification. To a lesser degree, insertion biases caused by the modified 
transposome responsible for tagmentation have also been observed.67 
Such issues related to coverage bias using Nextera XT have created significant obstacles in the 
use of whole-genome sequencing for AMR surveillance and outbreak investigation. The 
downstream effects of coverage bias have led to sequencing data corresponding to relevant 
AMR loci being lost, resulting in important clones requiring repeat sequencing. This increases 
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the time and cost burden required to successfully identify an AMR clone and control a potential 
outbreak.  
To address the issues associated with Nextera XT, Illumina launched the Nextera Flex library 
preparation kit.72 Nextera Flex uses a modified bead-linked transposome, which claims to 
decrease bias in tagmentation and contain an inbuilt fragment size normalisation mechanism.72 
The bead-linked transposomes remove the need for a strict input DNA volume requirement by 
only tagmenting DNA after the bead is saturated with DNA.72 Both library preparation kits 
require a subsequent limited cycle PCR step that uses the inserted DNA from tagmentation to 
incorporate indexes, P5 and P7 sequences onto the ends of the tagmented DNA fragments, and 
to amplify the DNA libraries.66, 72 The indexes serve as a unique barcode for each sample 
allowing multiple samples to be sequenced on the same run, while the P5 and P7 sequences are 
necessary for the DNA library to adhere to the flow cell and participate in cluster generation and 
the sequencing by synthesis reaction.66, 72 Advantages of using Illumina sequencers include the 
low cost per base, high throughput, and high accuracy.65 Major limitations of Illumina 
sequencing other than coverage bias include the difficulty in resolving repeat regions that are 
longer than the reads that Illumina sequencing instruments produce.73, 74 
1.5.2 Third-generation sequencing technologies 
The third-generation of sequencing technology had the capacity to resolve repetitive genomic 
regions that Illumina sequencers could not through producing much longer reads.75 The Oxford 
Nanopore MinION is a third generation portable sequencing device that weighs only 90 g.76 
Sequencing is carried out on a flow cell containing 2,048 nanopores that sits within the device, 
with each nanopore performing the sequencing reaction independently.76 Prior to sequencing 
genomic DNA, an adapter must be ligated onto both ends of each DNA fragment.76 The 
adapters facilitate the loading of an enzyme onto the 5’ end of the DNA molecule, which 
ensures that the DNA molecule only moves through the pore in one direction.76 When the DNA-
adapter complex is captured, it passes through the pore and the sensor detects changes in the 
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ionic current caused by the nucleotide sequences moving through.76 These ionic current changes 
are interpreted computationally as a sequence of three-six nucleotide k-mers.76 
One of the main advantages of using Oxford Nanopore MinION over other sequencing 
technologies is that the read lengths are much longer than the dominant second-generation 
sequencing platforms, being capable of producing 300 kb reads.76 This property can be used to 
resolve repetitive regions of a genome, which is a major obstacle with short read sequencing.76 
Sequencing using an Oxford Nanopore MinION also requires a much simpler process for 
sample preparation and does not require nucleotides or polymerases.75 Its tiny size and 
simplicity has allowed it to be used in locations where high throughput sequencing machinery is 
not accessible, such as in the Arctic, the Antarctic and the International Space Station.77 It has 
had applications in diagnosis of Ebola virus during the epidemic in West Africa, and the Zika 
virus epidemic in Brazil.78, 79 Despite its novel applications, the main limitation associated with 
Oxford Nanopore MinION sequencing is that the accuracy is much lower than second-
generation sequencing technologies, with accuracy reports varying between 20-92%.76, 80 To 
compensate for the low accuracy observed in Oxford Nanopore reads, they can be used in 
hybrid assemblies alongside the short reads produced by an Illumina sequencing platform.81 
This involves de novo assembling the Illumina short reads and then aligning the contigs to the 
Oxford Nanopore long reads, which can assist in joining the contigs to produce scaffolds, and 
successfully characterise the full genome in some cases.81 
1.5.3 Bias associated with second-generation sequencing 
Bias can be introduced at many different stages of library preparation, sequencing by synthesis 
and post-sequencing processing. Dohm et al. (2008) were the first to suggest that library 
preparation may introduce bias into a sequencing dataset through the PCR steps that are 
necessary for library preparation and incorporation of index sequences.74 Subsequent studies 
further supported this hypothesis, leading to the preference for PCR-free library preparation 
protocols in many different applications of whole-genome sequencing.70, 71, 82-84 Others have 
found that while PCR during library preparation contributes most to coverage bias, it can be 
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remedied through optimisation of the standard protocol.68, 73, 85 While the role of PCR in 
coverage bias has been documented repeatedly, the role of the transposase used during 
tagmentation in coverage bias is not frequently discussed. 
The wild-type Tn5 transposases generally have low target specificity, although a preference for 
insertion in certain genomic regions has been observed in vivo.86 A nine base pair (bp) 
consensus sequence was identified as its target, which was documented by Goryshin et al. 
(1998) as 5’A-GNTYWRANC-T, where N represents any nucleotide, R represents A or G, W 
represents A or T, and Y represents C, or T.87 Adey et al. (2010) discussed the modified 
tagmentation transposase possessing a slight insertion bias that weakly resembled the insertion 
bias of wild type Tn5.67 However this was not further explored as the advantages of enzymatic 
tagmentation were considered to overwhelmingly outweigh the slight increase in bias.67 
Subsequent studies comparing the Nextera and Nextera XT library preparation kits against other 
market leaders that do not use enzymatic fragmentation have had mixed conclusions.69, 70, 83, 88, 89 
None have critically evaluated the Nextera Flex library preparation kit in the context of AMR 
research.  
1.6 Project aims 
An ongoing study has identified phenotypic resistance against CIAs in E. coli isolates from little 
penguins and feral pigeons on Penguin Island, Western Australia. Based on the information 
above, it was hypothesised that this was more likely to be the result of horizontal gene transfer 
than a single successful AMR clone. However, the current tools that are widely used for 
sequencing of small genomes frequently produce data with uneven and biased coverage which 
can result in sequencing data loss and difficulty in identifying mobile genetic elements. It has 
been suggested that the Nextera Flex library preparation kit may overcome this limitation. To 
test this, this project aimed to: 
1. Determine whether the Nextera Flex library preparation kit outperforms Nextera XT in 
reducing the coverage bias associated with whole-genome sequencing, and therefore 
provide more reliable AMR information from the chosen isolates 
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2. Detect and characterise the mobile genetic elements responsible for the AMR observed 
in the faecal E. coli isolates from little penguins and feral pigeons on Penguin Island 
using a combination of second and third-generation sequencing technologies. 
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2. Materials and methods 
2.1 Sample preparation 
Escherichia coli that displayed a CIA resistant phenotype were isolated by S. Mukerji as part of 
an ongoing research programme evaluating the carriage of CIA resistant bacteria in Australian 
wild birds.90 Isolates used in this study were from faecal samples collected from feral pigeons 
(Columba livia) and little penguins (Eudyptula minor) residing on Penguin Island, Western 
Australia. E. coli was isolated from faecal swabs after four-hour incubation in buffered peptone 
water, via streaking onto both MacConkey agar with ciprofloxacin and Brilliance ESBL agar. 
To aid the library preparation kit comparison, four isolates with fully characterised genomes 
were also included in the study as positive controls. Isolates included one Salmonella enterica 
Typhimurium isolate from a clinically unwell cat (NCBI accession numbers KX810825 and 
KX777254), one E. coli isolate from a healthy pig (NCBI accession numbers MF174859 and 
MF174860), one equine Staphylococcus aureus isolate (NCBI accession numbers CP029166, 
CP029167, CP029165) and one human S. aureus isolate (NBCI accession numbers CP002114 
and CP002115).91-94 Samples (n = 24) were recovered from storage at -80oC by culture onto 
Columbia sheep blood agar (Micromedia), followed by overnight incubation at 37oC. An 
overview of isolate information is included in Table 4, with individual isolate information 
including phenotypic resistance data provided in Appendix I. Following recovery from frozen 
stock, species identification was confirmed using matrix-assisted laser desorption/ionisation 
time-of-flight (MALDI-TOF) mass spectrometer (Bruker).  
2.2 DNA extraction and quantitation 
Following species confirmation, DNA extraction was performed using the MagMAX™-96 
DNA Multi-Sample Kit (Thermo Fisher Scientific) with the following amendments to the 
manufacturer’s instructions. A small number of isolated single colonies from each sample were 
picked and suspended in 200 µL Multi-Sample DNA lysis buffer. All plate shaking steps were 
performed using a Compact Digital Microplate Shaker (Thermo Fisher Scientific) set to 900 
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RPM, and an additional plate shaking step was performed following colony addition to the lysis 
buffer. The MagMAX™ Express-96 Deep Well Magnetic Particle Processor (Life 
Technologies) was used with a modified version of the 4413021 DW Blood protocol where the 
RNase A step was omitted. DNA was eluted in 30 µL of each of the supplied elution buffers. 
DNA purity was assessed using a NanoQuant Plate™ (TECAN) and Spark® Multimode 
Microplate Reader (TECAN). The DNA concentration was calculated using a Qubit™ dsDNA 
HS Assay kit (Invitrogen). 
Table 4 Sample information for avian-origin E. coli isolated from feral pigeon and little penguin faecal samples from 
Penguin Island, Western Australia (n = 20). 
Source Number of isolates Selective media 
Feral Pigeon 5 MacConkey + Ciprofloxacin 
 5 Brilliance ESBL 
Little Penguin 5 MacConkey + Ciprofloxacin 
 5 Brilliance ESBL 
 
2.3 Library preparation with Nextera XT and Nextera Flex 
Library preparation was performed on extracted genomic DNA from all samples (n = 24) with 
both the Nextera XT library prep kit (Illumina) and the Nextera Flex library prep kit (Illumina) 
according to manufacturer’s instructions.66, 72 A detailed overview and comparison of both 
methodologies including pooling, denaturing and diluting steps is provided in Appendix II.  
2.4 Whole-genome sequencing using Illumina NextSeq 
Samples were sequenced on an Illumina NextSeq 500 platform using a V2 mid-output 2 x 150 
flow cell. FASTQ files were downloaded from BaseSpace after being de-multiplexed and 
subject to adapter trimming.95 This sequencing run produced two FASTQ files per isolate; one 
file corresponding to the Nextera XT library preparation kit and the other corresponding to the 
Nextera Flex library preparation kit. Quality control was performed on all FASTQ files using 
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FastQC, which reported quality metrics including per base sequence quality, per tile sequence 
quality, per sequence quality scores, per base sequence content, per sequence GC content, per 
base N content, sequence length distribution, sequence duplication levels, overrepresented 
sequences, and adapter content.96 After quality control, the FASTQ files were de novo 
assembled under default settings using SPAdes genome assembler v3.12.0.97 
2.5 Library preparation kit comparison 
For quality assessment of the de novo assemblies produced by SPAdes, QUAST provided a set 
of metrics including number of contigs, size of the largest contig, total length of assembly and 
N50 that functioned as indicators for overall contiguity of each assembly.98 The values produced 
by QUAST were used to determine whether there was any difference in de novo assembly 
quality that could be attributed to which library preparation kit was used prior to sequencing. 
The Kruskal-Wallis test was used for statistical analysis of this data (at an α of .05), after outlier 
removal and assumption testing with Levene’s statistics.  
The extent of GC content related bias was examined using the FastQC per sequence GC content 
metric.96 This calculated the GC content of each read in the FASTQ file as a percentage and 
plotted these values against a modelled GC content distribution based on the overall GC content 
of the organism’s genome.96 FastQC produced a warning if more than 15% of reads in a FASTQ 
file deviated from the modelled distribution, and a failure if more than 30% of reads deviated 
from the modelled distribution.96 This quality metric is based on the assumption that an 
unbiased sequencing dataset should have a normal distribution that peaks at the mean GC 
content of the genome, and datasets that do not conform to this assumption may contain GC 
content related bias.82 The output for both the Nextera XT and Nextera Flex FASTQ files were 
compared to assess whether either of library preparation kits produced a GC content related 
bias. 
The potential for tagmentation bias was also explored using FastQC with the per base sequence 
content metric, which calculated the average proportion of each of the four bases at each read 
position within a FASTQ file.96 The FASTQ files were merged based on which library 
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preparation kit was used, producing one FASTQ file for Nextera XT samples and one for 
Nextera Flex samples. Each merged FASTQ file was run through FastQC, and the per base 
sequence content output was compared visually for each library preparation kit to confirm 
whether either of the tagmentation enzymes favoured a sequence motif. 
To investigate whether there were any gaps in coverage that were unique to either of the library 
preparation kits, each set of FASTQ files from the avian E. coli isolates from Penguin Island 
were mapped to the E. coli K12 MG1655 reference genome using Bowtie2 under default 
settings.99, 100 The swine-origin E. coli isolate, as well as the feline S. enterica and both human 
and equine S. aureus isolates, had fully assembled genomes by PacBio SMRT cell sequencing. 
Therefore the FASTQ files from these isolates were mapped to their respective assemblies using 
Bowtie2 under default settings.99 Each isolate outputted two alignment files; one file 
corresponding to each of the library preparation kits. Separate alignment files were generated 
for each plasmid from previously characterised isolates. Using SAMtools, each alignment file 
was then compressed and sorted before a coverage count at each position across the reference 
genome for each sample was computed.101 The coverage counts were explored graphically using 
ggplot2 to visually determine regions of low coverage and establish whether the extent of low 
coverage differed depending on which library preparation kit was used.102 Firstly, a frequency 
histogram was produced using the coverage count data from each alignment file to observe 
whether there were more positions of low coverage that corresponded to one library preparation 
kit over the other. To determine whether there were specific regions of low coverage across the 
reference genome that were unique to one library preparation kit, the coverage data was also 
plotted on a bar graph with the position in the reference genome on the x-axis and coverage 
count on the y-axis. The mean coverage counts for each alignment file were tested for statistical 
significance with a one-way analysis of variance (ANOVA) (α of .05) to verify whether mean 
coverage was different based on which library preparation kit was used following outlier 
removal and assumption testing with Shapiro-Wilk and Levene’s statistics. 
The average fragment size for each sample was calculated prior to pooling in preparation for 
whole-genome sequencing with the LabChip GX Touch HT Nucleic Acid Analyzer. This data 
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was then tested for a statistical significance retrospectively using a Welch’s ANOVA (α of .05) 
to establish whether the fragment size distribution was different depending which library 
preparation kit was used following assumptions testing with Shapiro-Wilk statistics and outlier 
removal.  
2.6 Assessment of AMR in avian origin E. coli isolates 
After sequencing with the Illumina NextSeq500 and subsequent quality control and de novo 
assembly, the FASTA file produced by SPAdes for each isolate was uploaded to Center for 
Genomic Epidemiology (CGE) and parsed through the Bacterial Analysis Pipeline to detect 
AMR genes and determine MLST.103 The information provided by the CGE Bacterial Analysis 
Pipeline additionally included the location of each AMR gene within the assembly.103 Each 
FASTA file was also run through mlplasmids which predicted whether each contig formed part 
of the bacterial chromosome or a plasmid.104 This combined information was used to infer 
whether AMR genes were located on the chromosome or a plasmid. Contigs containing AMR 
genes were also uploaded to Galileo AMR to annotate AMR associated mobile genetic 
elements.105 Mobile genetic elements containing genes conferring resistance to CIAs or greater 
than three different antimicrobial classes were extracted from the FASTA files using CLC 
Genomics Workbench 11.0.1 (Qiagen Bioinformatics). The sequence for each mobile genetic 
element of interest was then used as a reference to map all avian E. coli FASTQ files against 
using Geneious 11.1.5 (Biomatters) to confirm whether any mobile genetic element conferring 
multidrug-resistance or CIA resistance was present in more than one isolate throughout the 
avian origin E. coli isolates taken from Penguin Island. 
To detect mutations associated with quinolone resistance, Snippy v4.1.0 (available from 
https://github.com/tseemann/snippy) was used to detect the following single nucleotide 
polymorphisms (SNPs) in all isolates: C248T, G259A, A2034C/T and T2482G in gyrA, 
C555A/G in gyrB, G239T and A1425C/T in parC and A406G in parE.106 The E. coli K12 
MG1655 sequence for gyrA, gyrB, parC, and parE was used as a reference.100  
33 
 
A phylogenetic tree was constructed to investigate the clonal similarity among CIA resistant E. 
coli isolates from Penguin Island, firstly by producing a core SNP alignment using Snippy 
v4.1.0  (available from https://github.com/tseemann/snippy) and E. coli K12 MG1655 as the 
reference genome.100 The core SNP alignment was then used for maximum likelihood 
phylogenetic tree construction with RAxML v8.2.11, then regions of recombination were 
removed using ClonalFrameML v1.11.107, 108 The final phylogenetic tree was annotated using 
iTOL 4.3.3.109  
2.7 Whole-genome sequencing using Oxford Nanopore MinION 
In an attempt to fully assemble an AMR-conferring mobile genetic element, a subset of samples 
(n = 5) were sequenced using the Oxford Nanopore MinION (Table 5). Three isolates were 
among the samples included in the library preparation kit comparison from Penguin Island, 
Western Australia. The remaining two were from faecal swabs from Silver Gulls 
(Chroicocephalus novaehollandiae). Isolates were selected for resequencing using the Oxford 
Nanopore MinION based on which AMR genes were found with Illumina sequencing. 
Table 5 Isolate information for samples sequenced using Oxford Nanopore MinION. 
Source Location Sample ID Isolated organism 
Feral Pigeon Penguin Island, WA FP 202 CIPA E. coli 
Silver Gull Cottesloe, WA 247 CIPA E. coli 
Little Penguin Penguin Island, WA LP 251 ESBA E. coli 
Feral Pigeon Penguin Island, WA FP 209 ESBA E. coli 
Silver Gull Melbourne, VIC 585 CREA Cronobacter sp. 
 
Gram-negative bacteria were isolated from faecal samples by S. Mukerji as part of a separate 
study through streaking onto Brilliance CRE, Brilliance ESBL and MacConkey Agar 
supplemented with ciprofloxacin following four-hour incubation in buffered peptone water, and 
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stored at -80oC in brain heart infusion broth with 20% glycerol. Each isolate was recovered from 
frozen stock through subculture onto Columbia sheep blood agar (Micromedia), and subject to 
DNA extraction using the MagMax™ DNA Multi-Sample Kit as described previously, with the 
following exceptions. Single colonies from each isolate were picked from their respective agar 
plates and suspended in 5 mL Luria-Bertani broth, Miller (Oxoid). Each sample was incubated 
for 15 hours at 37oC, then pelleted by centrifuging at 2,516 x g for 5 minutes. To account for the 
increased cell load, quantities of lysis buffer and isopropanol were doubled from the 
MagMAX™ DNA Multi-Sample kit manufacturer’s protocol, and vortexing was avoided to 
prevent DNA shearing. DNA purity was assessed using the NanoQuant Plate™ (TECAN), and 
concentration was calculated using the Qubit™ dsDNA HS Assay kit (Invitrogen). Average 
DNA fragment size was determined using 2% agarose gel electrophoresis. DNA was diluted to 
55 ng µL with nuclease-free water in preparation for sequencing. Samples were sequenced 
using the Oxford Nanopore MinION 1b on an R9.4.1 flow cell according to manufacturer’s 
instructions.110 
Sequencing data was demultiplexed using MinKNOW (Oxford Nanopore Technologies), 
adapters were trimmed using Porechop v0.2.4 (available from 
https://github.com/rrwick/Porechop), and reads were quality filtered using NanoFilt, which 
removed reads with an average phred quality score below 10.111 The processed Oxford 
Nanopore MinION FASTQ file was utilised in a hybrid assembly alongside Illumina reads 
using both Unicycler v0.4.8-beta under default settings and SPAdes genome assembler v3.12.0 
using the hybrid option.97, 112 Prior to being incorporated in the hybrid assemblies, Illumina 
FASTQ files were trimmed using the Trimmomatic SLIDINGWINDOW trimmer, which 
trimmed reads where average quality dipped below 20 across a 5 bp window.113 Both hybrid 
assemblies were visualised using Bandage and assessed for quality using QUAST.98, 114 The 
hybrid assembly produced by Unicycler was of higher quality than the SPAdes hybrid 
assembly. Therefore, the SPAdes hybrid assembly was omitted from further analysis. 
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The Unicycler hybrid assembly was annotated with RAST, then run through the CGE Bacterial 
Analysis Pipeline to establish which AMR genes were located chromosomally and which were 
located on plasmids.103, 115 The Unicycler assembly was then uploaded to Galileo AMR for more 
detailed annotation of AMR associated mobile genetic elements.105 Relevant mobile genetic 
elements were extracted and analysed as described previously to determine whether any were 
present in more than one avian E. coli isolate and potentially explain the high frequency of 
resistance against CIAs in wild birds from Penguin Island, Western Australia. Relevant mobile 
genetic elements were uploaded to NCBI Blast to determine whether there were any similar 
mobile genetic elements present in the database.
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3. Results  
3.1 Library preparation kit comparison 
This study found that the Nextera XT library preparation kit yielded whole-genome sequencing 
data with more coverage bias than the Nextera Flex library preparation kit. The coverage data 
generated by SAMtools was analysed using ggplot2.101, 102 A frequency histogram was produced 
to observe patterns in coverage levels based on which library preparation kit was used prior to 
sequencing. A bar plot was then produced to verify whether these coverage patterns led to 
coverage bias across the genome. 
In samples where mean coverage was very similar irrespective of which library preparation kit 
was used, Nextera Flex coverage was more tightly distributed with less variation (Figure 5a). 
Additionally, there was a higher frequency of low coverage positions in the Nextera XT 
prepared sample (Figure 5a). As a result, the Nextera Flex prepared samples produced data with 
more even coverage across the genome than its Nextera XT counterpart and covered some 
regions that the Nextera XT dataset missed (Figure 5a). This was also observed in samples 
where mean coverage in the Nextera Flex dataset was much higher (Figure 5b). 
In cases where mean coverage was much higher in the Nextera XT prepared isolate, steep dips 
in coverage were observed which the Nextera Flex dataset covered more evenly (Figure 5c). 
The S. aureus coverage data had a notably different distribution to the E. coli and S. enterica 
samples, with the Nextera XT data being very broadly distributed and overall much higher mean 
coverage than the Nextera Flex data (Figure 5d). Despite this, steep dips were observed in the 
Nextera XT dataset that were covered by the Nextera Flex kit more evenly (Figure 5d). Plasmid 
coverage data that was taken where available followed the same patterns observed in 
chromosomal coverage data (Appendix IV). 
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Figure 5 Coverage count data displayed as both frequency histograms (left) and bar plots (right). Figures 5a-d each 
represent a distinct coverage pattern observed in the library preparation kit comparison. a and c are avian-origin E. 
coli, b is feline-origin S. enterica and d is equine-origin S. aureus. Coverage data for all isolates is in Appendix III. 
Legend 
Nextera Flex 
Nextera XT 
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To explore whether the coverage bias findings may have been influenced by overall coverage 
differences between each test group, a one-way ANOVA was used to determine whether mean 
coverage was influenced by which library preparation kit was used (Figure 6). Shapiro-Wilk 
statistics indicated that the normality assumption was supported for both the Nextera Flex and 
Nextera XT datasets. Levene’s statistics confirmed that the homogeneity of variance assumption 
was supported. Higher mean coverage was observed in Nextera Flex samples compared to 
Nextera XT samples, although this was not statistically significant (p = .271). This finding 
supported the assumption that the coverage bias observed in samples was not a result of uneven 
pooling or higher DNA input. 
 
 
Figure 6 Comparison of the mean sequencing coverage based on which library preparation kit was used. Results of 
the one-way ANOVA showed that there was no significant difference in the mean coverage attributed to which 
library preparation kit was used (p = .271). 
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During library preparation, fragment size distribution was checked using the LabChip GX 
Touch HT Nucleic Acid Analyzer following post-PCR clean-up. Outliers were removed, and 
data were log-transformed then tested retrospectively using a Welch’s ANOVA (Figure 7). 
Shapiro-Wilk statistics supported the normality assumption. The results indicated that the 
Nextera Flex prepared isolates had a lower and more consistently distributed fragment length. 
This difference in average fragment length based on which library preparation kit was used was 
statistically significant (p = .000004373).  
 
 
Figure 7 Comparison of log average fragment size produced by each of the library preparation kits revealed that the 
Nextera Flex kit yielded fragments with a significantly different size distribution to the Nextera XT kit (p = 
.000004373).  
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A major difference between the Nextera XT and Nextera Flex library preparation kits is the 
transposome used for tagmentation.116 To determine whether a tagmentation bias was present in 
either library preparation kit, the FastQC per base sequence content metric was used.96 This 
metric plotted the average proportion of each of the four bases at each position across all the 
reads in a FASTQ file. In an unbiased library, notable differences in the proportion of bases 
across each read are not expected. However, the results from this module suggested that the 
tagmentation enzyme in both library preparation kits preferentially tagmented DNA with the 5’-
GTNYWRNAC sequence motif. 
 
Figure 8 Line graph plotting the position across each read on the x-axis, and the proportion of each base shown on 
the y-axis. Nextera XT data is shown in a, Nextera Flex data shown in b. The first ten positions across the read 
indicate that a sequence motif is preferentially tagmented by the transposome in both library preparation kits. 
 
To detect potential GC content related bias between the two library preparation kits, the FastQC 
per sequence GC content metric was used.96 Summarised data is included in Figure 9; complete 
data is included in Appendix V. A warning was produced when more than 15% of the reads in a 
FASTQ file deviated from the modelled distribution, which occurred in 91% of the Nextera 
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Flex samples and only 58% of Nextera XT samples. In the E. coli and S. enterica samples 
prepared for sequencing with the Nextera Flex library preparation kit, regions with 50% GC 
content appeared to be over-represented, and regions with between 60-80% GC content 
appeared under-represented. This bias was not observed in S. aureus isolates prepared with 
either of the library preparation kits.  
a E. coli Nextera XT (n = 21) 
 
b E. coli Nextera Flex (n = 21)
 
c S. enterica Nextera XT (n = 1) 
 
d S. enterica Nextera Flex (n = 1)
 
e S. aureus Nextera XT (n = 2) 
 
f S. aureus Nextera Flex (n = 2) 
 
Figure 9 Graph plotting mean GC content on the x-axis and number of reads on the y-axis. The graph was generated 
by FastQC per sequence GC content metric. To provide an overview of the results, FASTQ files were merged 
together if they were from the same species and prepared for sequencing with the same library preparation kit.  
 
To assess differences in de novo assembly quality based on which library preparation kit was 
used, QUAST assembly quality metrics inclusive of number of contigs, largest contig, total 
Legend 
GC content 
distribution 
 
Theoretical 
GC content 
 
Region of 
interest 
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length of assembly and N50 were analysed using a Kruskal-Wallis test for each metric (Figure 
10).98 Data points more than three standard deviations from the mean were removed and 
Levene’s statistics supported the homogeneity of variance assumption. The Kruskal-Wallis test 
was not statistically significant for any of the metrics tested. All samples were de novo 
assembled using SPAdes under default parameters, after modifications of read trimming and k-
mer length established that the default settings with untrimmed reads produced the highest 
quality assemblies.97  
a 
 
c 
 
b 
 
d 
 
Figure 10 Comparison of assembly quality metrics based on which library preparation kit was used. The difference 
in number of contigs based on which library preparation kit was used was not statistically significant (p = .8618), nor 
was largest contig (p = .3928), total assembly length (p = .9495) or N50 (p = .6126). 
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Table 6 A summary of the outcomes of the library preparation kit comparison. 
 Nextera XT Nextera Flex 
DNA input quantity Precisely 1 ng  Between 1-500 ng ✓ 
 
Insert size Interquartile range 
of insert sizes  
= 360.5 
 Interquartile range 
of insert sizes  
= 60.5 
✓ 
 
 
 
Coverage bias Present  Reduced ✓ 
 
Tagmentation bias 0% of isolates 
passed FastQC per 
base sequence 
content metric 
 0% of isolates 
passed FastQC per 
base sequence 
content metric 
 
 
 
 
 
De novo assembly quality ≈ 120 contigs for E. 
coli genome 
✓ ≈ 120 contigs for E. 
coli genome 
✓ 
 
 
GC content bias 58% of isolates 
produced a warning 
for FastQC per 
sequence GC 
content metric 
✓ 91% of isolates 
produced a warning 
for FastQC per 
sequence GC 
content metric 
 
 
 
 
 
 
AMR gene detection CGE detected all 
the same AMR 
genes as in the 
Nextera Flex 
prepared isolate 
✓ CGE detected all 
the same AMR 
genes as in the 
Nextera XT 
prepared isolate 
✓ 
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3.2 Presence of AMR in avian origin E. coli isolates 
Analysis of each avian-origin E. coli isolate from Penguin Island using the CGE Bacterial 
Analysis Pipeline revealed that all isolates (n = 20) harboured at least one gene conferring 
resistance against CIAs (Table 7).103 Isolates belonged to 13 different MLSTs. There was no 
difference in the AMR gene information based on which library preparation kit was used, and 
no isolates harboured AMR genes against carbapenems, polymyxins or glycopeptides. 
Investigation of AMR against extended-spectrum cephalosporins among the avian origin E. coli 
isolates found that out of the 14 isolates that were phenotypically resistant to ceftriaxone, 92.9% 
(13/14) of these isolates carried a CTX-M type ESBL (Table 7, Appendix I). The most prevalent 
CTX-M gene was blaCTX-M-15 found in 69.2% (9/13) of ESBL producing isolates. 15.4% (2/13) 
of CTX-M type ESBL carriers contained blaCTX-M-14, and 15.4% (2/13) contained blaCTX-M-27. 
Further analysis of the blaCTX-M genes revealed that isolates containing blaCTX-M-15 always had 
ISEcp1 upstream (Figure 11a). 66.6% (6/9) isolates containing blaCTX-M-15 harboured the gene 
chromosomally, and 55.6% (5/9) of blaCTX-M-15-positive isolates contained the gene within a Tn2 
type transposon (Figure 11b). Two of these isolates contained Tn2 with blaCTX-M-15 
chromosomally, while the other three contained it within a plasmid. Additionally, a large 
plasmid-mediated MDR island was found in one isolate containing strB, strA, blaCTX-M-15, 
blaTEM-1b, qnrS1 and sul2 (Figure 11c). Extracting the MDR island in silico using CLC 
Genomics Workbench 11.0.1 (Qiagen Bioinformatics), then mapping all relevant FASTQ files 
to it using Geneious 11.1.5 (Biomatters) confirmed that this resistance island had not been 
transferred to other isolates.
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Table 7 Genes conferring AMR in avian origin E. coli isolates from Penguin Island (n = 20) detected by the CGE Bacterial Analysis Pipeline 
Sample ID Source Resistance gene(s) 
FP222 CIPA Feral pigeon (Columba livia) aadA1, aadA2, blaTEM-1B, cmlA1-like, dfrA12, floR-like, mph(A), qnrS1, strA, strB-like, sul2, sul3, 
tet(A)-like 
FP225 CIPA Feral pigeon (Columba livia) blaCTX-M-15, blaTEM-1B, dfrA17, mph(A), strA, strB-like, sul2, tet(A) 
LP250 ESBA Little penguin (Eudyptula minor) aadA5, blaCTX-M-15, blaOXA-1-like, dfrA17, mph(A), sul1 
LP249 ESBA Little penguin (Eudyptula minor) aadA5, blaCTX-M-15, blaOXA-1-like, dfrA17, dfrA5, mph(A), sul1 
LP143 ESBA Little penguin (Eudyptula minor) blaCTX-M-15, blaTEM-1B, qnrS1, tet(A) 
FP222 ESBA Feral pigeon (Columba livia) blaCTX-M-14 
FP209 ESBA Feral pigeon (Columba livia) blaCTX-M-15, blaTEM-1B, qnrS1, strA, strB, sul2, tet(A) 
FP202 ESBA Feral pigeon (Columba livia) aadA5, blaCTX-M-27, dfrA17, mph(A), strA, strB-like, sul1, sul2, tet(A) 
LP143 CIPA Little penguin (Eudyptula minor) blaCTX-M-15, blaTEM-1B, qnrS1, tet(A) 
LP251 CIPA Little penguin (Eudyptula minor) aac(3)-IId-like, blaTEM-1B, erm(42)-like, mph(A)-like, strA, strB, sul3, tet(B) 
FP225 ESBA Feral pigeon (Columba livia) blaCTX-M-15, blaTEM-1B, dfrA17, mph(A), strA, strB-like, sul2, tet(A) 
LP233 CIPB Little penguin (Eudyptula minor) aac(3)-IId-like, aadA5, blaTEM-1B, dfrA17, mph(A), strA, strB-like, sul1, sul2, tet(A) 
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FP219 ESBA Feral pigeon (Columba livia) blaCTX-M-15 
LP233 ESBA Little penguin (Eudyptula minor) blaCTX-M-14 
FP202 CIPA Feral pigeon (Columba livia) aadA5, blaCTX-M-27, dfrA17, mph(A), strA, strB-like, sul1, sul2, tet(A) 
LP239 CIPA Little penguin (Eudyptula minor) blaTEM-1B, catA1-like, dfrA17, strA, strB, sul2, tet(B) 
FP219 CIPA Feral pigeon (Columba livia) aadA1, aadA2, aph(3')-Ia, cmlA1-like, dfrA14-like, sul3 
FP209 CIPA Feral pigeon (Columba livia) aadA2-like, blaTEM-1B, dfrA12, floR-like, mph(A), sul1, sul3, tet(A)-like 
LP251 ESBA Little penguin (Eudyptula minor) aac(3)-IIa-like, aac(6')Ib-cr, aadA5, blaCTX-M-15, blaOXA-1, blaTEM-1B, catA1-like, catB3-like, dfrA17, 
mph(A)-like, sul1, tet(B) 
LP233 CIPA Little penguin (Eudyptula minor) blaTEM-1B, catA1-like, dfrA17, tet(A)-like 
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Figure 11 The different mobile genetic elements associated with blaCTX-M-15 within the avian E. coli isolates, 
including blaCTX-M-15 downstream from ISEcp1 (a), blaCTX-M-15 with ISEcp1 located inside a Tn2 transposon (b), and a 
large resistance island containing strB, strA, blaCTX-M-15, blaTEM-1b, qnrS1, and sul2. Diagrams were generated using 
Galileo AMR.105 
 
The CGE Bacterial Analysis Pipeline found that 55% of the avian E. coli isolates (11/20) 
harboured mph(A).103 Further analysis using Galileo AMR found that all but one mph(A) 
positive isolates contained the entire macrolide phosphotransferase gene cluster consisting of 
mph(A), mrx, and mph(R). 105 The macrolide phosphotransferase gene cluster was often found 
in proximity to a class 1 integron containing sul1, dfra17, and aadA1, with the entire group of 
AMR genes found within a composite transposon flanked by IS26 (Figure 12).   36.4% (4/11) of 
mph(A) positive isolates contained the entire composite transposon, with the remaining isolates 
containing partial versions of it (Figure 12). Presence of the entire composite transposon 
provided AMR genes against folate pathway inhibitors, aminoglycosides, and macrolides. 
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Figure 12 Diagram displays the presence of a mobile genetic element conferring resistance to macrolides, folate pathway inhibitors, and aminoglycosides in 11 isolates. Presence of relevant sequence is 
shown in black, and absence in red.
49 
 
Comparing the presence of the composite transposon conferring AMR against macrolides, 
folate pathway inhibitors and aminoglycosides to the relevant phenotypic AMR information 
found that out of the four isolates containing the entire composite transposon, all had phenotypic 
resistance to sulfamethoxazole with trimethoprim (Appendix I). However, only two had 
phenotypic resistance to gentamycin. All isolates that harboured dfrA17 had phenotypic 
resistance to sulfamethoxazole with trimethoprim, although some isolates that did not contain 
dfrA17 were also phenotypically resistant to sulfamethoxazole with trimethoprim due to the 
presence of a different dfrA variant (Appendix I). 
A mobile genetic element conferring multidrug-resistance to aminoglycosides, phenicols, and 
folate pathway inhibitors was found integrated chromosomally in one isolate. It contained a 
class 1 integron with six gene cassettes with a partial Tn21 transposon upstream from the 5’-CS 
(Figure 13). Mapping all FASTQ files back to this sequence confirmed that it had not been 
passed on to any other avian origin E. coli isolates in this study. 
 
Figure 13 Mobile genetic element conferring resistance to aminoglycosides, phenicols, and folate pathway inhibitors 
found in one avian E. coli isolate. 
 
Analysis of quinolone resistance present among the avian origin E. coli isolates found that out 
of the 14 isolates that were phenotypically resistant to ciprofloxacin, 100% (14/14) harboured 
the C248T substitution in gyrA, and 92.9% (13/14) contained the C555A/G SNP in gyrB. 85.7% 
(12/14) of this subset contained the A2034C/T SNP in gyrA and the A406G SNP in parE. The 
A1425C/T SNP in parC was found in 78.6% (11/14) of phenotypically ciprofloxacin-resistant 
isolates, and the A2034C/T SNP in gyrA was found in 64.3% (9/14). The G239T substitution in 
parC was found in only 50% (7/14) of isolates in this subset, and the G259A substitution in 
gyrA was found in only 35.7% (5/14). Plasmid-mediated quinolone resistance genes were only 
found in 28.6 % (4/14) of phenotypically ciprofloxacin resistant isolates; qnr in three cases and 
aac(6’)-Ib-cr in one (Figure 14). 
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Figure 14 Maximum likelihood tree based on 52,314 SNPs showing the clonal relationship between each avian origin E. coli isolate from Penguin Island, in addition to CIA resistance genes and 
relevant SNPs in QRDRs. E. coli K12 MG1655 was used as a reference. 
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3.3 Hybrid assembly of multidrug-resistant isolate 
Whole-genome sequencing using the Oxford Nanopore MinION was only successful in two out 
of five isolates despite repeat sequencing on the washed flow cell. Performing a hybrid 
assembly with Unicycler v0.4.8-beta was able to close the genome for one isolate (Table 8), 
while the SPAdes hybrid assembly could not close either genome. Completing the assembly for 
this isolate revealed that all the β-lactamase genes including the ESBL gene, in addition to a 
PMQR gene and a phenicol resistance gene were located on a resistance island within the 
chromosome (Figure 15). Further analysis found that this resistance island was unique to this 
isolate. The hybrid assembly also successfully characterised the composite transposon carrying 
the macrolide phosphotransferase cluster and class 1 integron conferring AMR against folate 
pathway inhibitors and aminoglycosides (Figure 12), which could not be achieved with Illumina 
sequencing alone. 
Table 8 Information for complete genome assembly of LP251 ESBA, an MDR E. coli ST648 isolate from the little 
penguin that was phenotypically resistant to at least eight different antimicrobial classes described in Table 2. 
Name Type Length (bp) AMR genes 
1 Chromosome 5,180,132 aac(6')Ib-cr, aac(3)-IIa, 
blaTEM-1B, blaOXA-1, blaCTX-M-
15, catB3 
2 Plasmid IncFIA 127,802 catA1, tet(B) 
3 Plasmid IncY 87,755 aadA5, mph(A), sul1, dfrA17 
4 Plasmid IncB/O/K/Z 77,338 None 
5 Plasmid 47,632 None 
6 Plasmid ColRNAI 7,939 None 
7 Plasmid Col8282 4,091 None 
8 Plasmid  3,373 None 
9 Plasmid Col(MG828) 3,004 None 
10 Plasmid Col(BS512) 2,101 None 
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Figure 15 Resistance island located chromosomally in LP251 ESBA consisting of a partial Tn2 transposon, with a 
composite transposon containing a partial class 1 integron, and ISEcp1 upstream from blaCTX-M-15. 
 
Uploading the resistance island from Figure 15 to NCBI BLAST found that the same mobile 
genetic element has been found chromosomally in a clinical E. coli isolate from Bangladesh 
(NCBI accession number CP034389), and in multiple plasmids from Klebsiella pneumoniae 
(NCBI accession numbers CP032212, CP034282, CP023841), Salmonella enterica 
Typhimurium (NCBI accession number CP021463) and E. coli (NCBI accession number 
MG878867).
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4. Discussion 
4.1 Library preparation kit comparison 
4.1.1 Coverage bias 
This study is the first to critically evaluate the performance of the Nextera Flex library 
preparation kit in the context of AMR research. This project aimed to determine whether the 
Nextera Flex library preparation kit was able to reduce sequencing bias associated with the 
library preparation steps of whole-genome sequencing, and therefore provide more reliable 
AMR information from the isolates used for this study. It was hypothesised that the Nextera 
Flex library preparation kit would not provide substantial enough improvements to the protocol 
to reduce the bias observed in the Nextera XT library preparation kit. To summarise, this study 
partially disproved this hypothesis, with the results indicating that the Nextera Flex library 
preparation kit did reduce coverage bias. However, other forms of sequencing bias such as 
tagmentation bias and GC content related bias appeared unchanged or worsened. Additionally, 
the practical outcomes of whole-genome sequencing such as de novo assembly quality and 
AMR gene detection did not change based on which library preparation kit was used.  
Comparing the performance of the Nextera XT and the Nextera Flex library preparation kits 
indicated that the Nextera XT library preparation kit contributed to more coverage bias than the 
Nextera Flex library preparation kit, where coverage bias was defined as a deviation from the 
expectation of uniform reads across a genome.117 The frequency histograms in Figure 5a-b 
showed that the samples corresponding to the Nextera XT library preparation kit had a higher 
frequency of low coverage positions than their Nextera Flex counterpart. This observation is 
most meaningful in Figure 5a where the mean coverage count was roughly the same regardless 
of which library preparation kit was used, though the Nextera Flex coverage counts were still 
more tightly distributed. The bar plots in Figure 5a showed that the Nextera Flex prepared 
sample often compensated for the sharp dips in coverage observed in the Nextera XT prepared 
sample, even when mean coverage was the same. This finding was consistent with a recent 
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study conducted by Illumina which found that when a 3 kb E. coli amplicon was prepared for 
sequencing with both the Nextera XT and the Nextera Flex library preparation kit, the latter led 
to more consistent, even coverage across the amplicon.116 
In Figure 5b, mean coverage in the Nextera Flex sample was much higher than in the Nextera 
XT counterpart, and in Figure 5c, mean coverage in the Nextera XT sample was higher than the 
Nextera Flex sample. At worst, this invalidated observations that the Nextera Flex library 
preparation kit provided more even coverage than Nextera XT in Figure 5b. At the same time, 
despite higher coverage from Nextera XT prepared samples in Figure 5c, regions of Nextera 
Flex coverage were still visible in the bar plot where there was a steep dip only present in the 
Nextera XT sample. This suggests that even in cases where mean coverage is higher in the 
Nextera XT kit, the Nextera Flex library preparation kit may provide more even coverage. This 
finding was complemented by the coverage data from the human and equine origin S. aureus 
isolates. In the S. aureus isolates (Figure 5d), Nextera XT coverage was much more broadly 
distributed and generally higher than the Nextera Flex sample, however, some regions had been 
completely lost in the Nextera XT sample that were covered by Nextera Flex.  
In the equine and human origin S. aureus, the feline origin S. enterica Typhimurium and the 
swine-origin E. coli, a fully assembled genome was available, and both chromosome and 
plasmid coverage data were used for analysis. Plasmid coverage data in Appendix IV 
demonstrates the same coverage patterns observed in the chromosome coverage data, and the 
coverage data shows these patterns in higher resolution since the data was uncompressed. 
Figure 5 and Appendix III only showed coverage data across the chromosome, as a fully closed 
reference genome for each isolate was not available. This was the first time the little penguin 
and feral pigeon origin E. coli isolates were sequenced, and subsequent de novo assembly failed 
to close the whole genome. The E. coli K12 MG1655 sequence was used as a reference genome 
for all the avian origin E. coli instead to calculate coverage counts, which is a slight limitation 
of this study.100 However, Figure 14 indicated that E. coli K12 MG1655 was not 
phylogenetically distinct from the E. coli isolates from Penguin Island, confirming that the E. 
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coli K12 MG1655 sequence was adequately similar to the avian origin E. coli isolates to be a 
valid reference genome. 
Ultimately, the factor that influences mean coverage the most is the quantity of input DNA. 
Despite controlling for this factor as tightly as possible, Figure 5b indicated that some libraries 
were unintentionally pooled at a higher concentration than others. The mean coverage data was 
plotted in Figure 6 and showed no significant difference based on which library preparation kit 
was used, suggesting that uneven pooling only affected coverage comparison for a minority of 
isolates. Additionally, samples that had a mean coverage of more than two standard deviations 
from the mean were considered outliers and excluded from the comparison. Despite the 
coverage bias only being present in Nextera XT samples, there was no difference in the AMR 
gene information based on which library preparation kit was used. Furthermore, few regions of 
the genome appeared to be lost entirely in the Nextera XT libraries, but this was likely due to 
the overall coverage being high enough to compensate for the dips that were observed.74 
4.1.2 Average fragment size yield 
Comparing the average fragment size yield of each library preparation kit found that Nextera 
Flex produced DNA libraries with a more consistent fragment size distribution than Nextera XT 
(Figure 7). One of the most important outcomes of library preparation is ensuring that fragment 
size is optimal for efficient cluster generation.118 When discussing fragment size, this includes 
both the adapter sequences and inserted DNA, where insert size is variable, and the adapter 
sequence length is consistent.118 During cluster generation, fragments that are too short cluster 
very efficiently and reduce the amount of useful data generated from the sequencing by 
synthesis reaction.118 Fragments that are too long are also suboptimal because they do not 
amplify efficiently and produce sparse clusters, which also reduces the amount of useful data 
yielded from the reaction.118 One of the main differences between Nextera XT and Nextera Flex 
were the bead-linked transposomes, which claimed to produce more consistent insert lengths 
during tagmentation.116 Following library amplification with Nextera Flex, a more 
comprehensive clean-up using double-sided solid phase reversible immobilisation (SPRI) beads 
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removed very low and very high molecular weight fragments to tighten the size distribution of 
the library.116 Based on the results, the combination of bead-linked tagmentation and double-
sided SPRI clean-up was effective in tightening the size distribution of each DNA library when 
using the Nextera Flex library preparation kit. This may have had a role in reducing coverage 
bias by increasing cluster generation efficiency and ensuring more even representation of the 
library. 
4.1.3 Tagmentation bias 
This study assessed the potential for tagmentation bias with the FastQC per base sequence 
content metric, which plotted the average proportion of each of the four bases at each position 
across all the reads in a FASTQ file.96 In an unbiased library, notable differences in the 
proportion of bases across each read are not expected. However, the results from this study 
suggested that the tagmentation enzyme in both library preparation kits preferentially tagmented 
DNA with the same sequence motif, as shown in Figure 8. Goryshin et al. (1998) reported the 
consensus target sequence of the wild type Tn5 transposase as 5’AGNTYWRANCT.87 The 
consensus target sequence for both the Nextera XT, and Nextera Flex tagmentation enzymes 
was 5’-GTNYWRNAC. While this consensus sequence does not resemble the target sequence 
for wild-type Tn5 at all, it is striking that the tagmentation enzyme for both kits appear to 
preferentially tagment the same sequence motif. The motif targeted by both tagmentation 
enzymes bears striking similarity to the wild-type Tn5 transposase, contrary to the finding by 
Adey et al. (2010) that the modified transposase targets a motif that only weakly resembles the 
wild-type.  
The presence of tagmentation bias has only been described briefly in the study by Adey et al. 
(2010) that first introduced enzymatic fragmentation during library preparation using the 
modified transposase.67 While several other studies briefly allude to the presence of 
tagmentation bias, presumably also related to GC content, the key source linked to this finding 
did not conclusively establish the role of the transposase in the GC bias reported.88 As a result, 
information on tagmentation bias in the literature is minimal. It should also be noted that the 
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tagmentation enzymes used in both Nextera XT and Nextera Flex library preparation kits are 
proprietary reagents for Illumina Inc. Therefore any further modifications to the transposome 
performed following the publication by Adey et al. (2010) are not publicly available. While the 
details of the changes to the transposome used in the Nextera Flex kit are unknown, the results 
of this study show that the enzyme may be the same or very similar to the transposome used in 
the Nextera XT kit. 
4.1.4 GC content bias 
The effect of GC content bias was detected in Nextera Flex samples to a much greater extent 
than in the Nextera XT samples (Figure 9), however, this bias did not appear to have influenced 
any other metrics of bias or suboptimal library construction that were assessed in this study. 
Despite this, the most documented form of sequencing bias is GC content bias, which was 
described as the relationship between read coverage and GC content.119 Identifying GC content 
related bias in this study was achieved by creating a theoretical GC content distribution that 
followed a normal distribution peaking at the mean GC content of the genome.82 The GC 
content of each read in the sample was then calculated and plotted against the theoretical 
distribution to identify if there have been any shifts or deviations from the theoretical 
distribution.82 In the E. coli and S. enterica isolates, while the peak was not shifted, genomic 
regions with a 50% GC content appeared overrepresented while regions with a 60-80% GC 
content appeared underrepresented. This was only observed in Gram-negative isolates which 
had a mean genomic GC content of 50%, but not observed in the Gram-positive isolates which 
had a GC content of 30%. It should be noted that the input DNA quantity was not adjusted for 
the S. aureus samples to account for the smaller genome size. Therefore, it is not clear whether 
the increased coverage was responsible for the absence of GC content related bias, or whether 
both the Nextera XT and the Nextera Flex library preparation kits provide less biased coverage 
in genomes with lower GC content. 
The first study reporting the relationship between GC content and coverage bias by Dohm et al. 
(2008) set the foundation for each following investigation of this phenomenon, despite being 
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flawed in many regards.74 The study was performed before methodological bias was ever 
reported between different sequencing runs, different flow cell lanes and even different people 
performing library preparation, therefore these factors were not adequately controlled for.74 
Additionally, they found a positive relationship between GC content and depth of coverage, 
which may have only occurred because the only two bacterial species that were sequenced for 
the investigation had low genomic GC content.74 Subsequent studies have found that GC 
content related bias reduces coverage of both GC poor and GC rich genomic regions.88, 117, 119 
Others have found that the bias caused by PCR during library preparation is not heavily linked 
to GC content; instead, it is more influenced by other factors such as the fidelity of the 
polymerase and the stochasticity of PCR.120 Additionally, some have argued that the GC content 
bias is only relevant when sequencing genomes that are very GC poor, and that this bias does 
not affect downstream processes such as de novo assembly unless the bias is severe.82, 84, 121 
Given that the Nextera Flex protocol required a five cycle PCR for library amplification, while 
the Nextera XT protocol required a 12 cycle PCR, it is unlikely that higher GC content regions 
were underrepresented due to PCR bias in this study. Overall, this finding may suggest that the 
Nextera Flex library preparation kit will not provide even coverage across samples with high 
genomic GC content, although this could not be firmly established without having included 
samples with a high GC content in the library preparation kit comparison. 
4.1.5 De novo assembly quality 
There was no marked improvement in the de novo assembly produced with the Nextera Flex 
prepared samples based on number of contigs, size of the largest contig, total assembly length or 
N50 (Figure 10), despite more even sequencing coverage. This finding was in line with the 
outcomes of a study by Huptas et al. (2016) which found that factors such as which assembler 
was used for de novo assembly and read and insert lengths had a more substantial influence on 
assembly quality than sequencing depth.84 Additionally, there were no differences in AMR gene 
detection based on which assembly was run through the CGE Bacterial Analysis Pipeline (data 
not shown). Therefore, despite the coverage bias unique to the Nextera XT libraries, the 
practical applications of the resulting sequencing data did not appear to suffer. 
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4.2 Presence of AMR in avian wildlife on Penguin Island 
It was hypothesised that the high levels of CIA resistant E. coli carriage detected in penguins 
and pigeons on Penguin Island, Western Australia, was most likely the result of horizontal gene 
transfer. This hypothesis was supported by evidence of several mobile genetic elements 
circulating AMR genes detected across multiple isolates, and lack of clonal similarity between 
the isolates studied (Figure 14). All avian origin E. coli isolates studied had both genotypic and 
phenotypic resistance against at least one CIA, constituting a serious public health concern. 
4.2.1 Resistance against extended-spectrum cephalosporins 
Out of all the E. coli isolates presenting as phenotypically resistant to extended-spectrum 
cephalosporins, carriage of blaCTX-M-15 was dominant, and was always found with ISEcp1 
upstream in a 2,971 bp transposition unit (Figure 11a). The ancestral blaCTX-M-15 originated from 
Kluyvera ascorbata, which naturally contained the ESBL gene chromosomally.122 It was then 
presumably mobilised from K. ascorbata through facilitation by ISEcp1.122 The transposition 
unit containing ISEcp1 and blaCTX-M-15 also included a 1,315 bp region of the K. ascorbata 
genome, further supporting this theory.123 It was first sequenced by Boyd et al (2004) who 
found that an IR-L at the 5’ end of ISEcp1 and an IR-R downstream from blaCTX-M-15 was 
responsible for transposition, with 5 bp direct repeats flanking each IR.124  The presence of 
ISEcp1 upstream from blaCTX-M-15 has been reported to enable the movement of its captured 
gene from plasmid to plasmid, plasmid to chromosome and chromosome to plasmid.125 Today, 
blaCTX-M-15 with ISEcp1 upstream is frequently reported in clinical Enterobacteriaceae isolates, 
both plasmid-borne and chromosomally integrated.37, 124-127 It is frequently detected in E. coli 
ST131 clones as a plasmid-mediated gene.38 Most isolates in this study that harboured blaCTX-M-
15 carried the gene chromosomally, which occurred in six different isolates with four different 
MLSTs. Source organisms included four different penguins and one pigeon. This finding is 
particularly concerning because chromosomally integrated genes are inherited with more 
stability than plasmid-mediated genes, meaning that the high incidence of blaCTX-M-15 detected in 
these isolates is likely to persist.33 
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The combination of ISEcp1 and blaCTX-M-15 was also detected inside a Tn2 transposon in five 
different isolates, with three carrying the transposon on a plasmid (Figure 11b). Tn2 transposons 
containing blaCTX-M-15 and ISEcp1 have been associated with IncF plasmids in E. coli, are 
flanked with 38 bp IRs, and contain a tnpA, tnpR and res site which ensures successful 
transposition.128 They have also been detected as part of large MDR regions as was observed in 
Figure 11c.129  
A single resistance plasmid could not be identified as the vehicle for Tn2 containing the 2,971 
bp ISEcp1-blaCTX-M-15 transposition unit in this study, which is consistent with the findings of a 
previous study of clinical E. coli isolates from western Sydney. The study found Tn2 containing 
the 2,971 bp transposition unit in IncF and IncI1 plasmids and suggested that homologous 
recombination may be responsible for the movement of blaCTX-M-15 throughout the different 
plasmid types.123 The presence of blaCTX-M-15 in the 2,971 bp transposition unit with ISEcp1 in 
some isolates (Figure 11a), in addition to the transposition unit found inside a Tn2 transposon 
(Figure 11b) in others both plasmid-borne and chromosomally integrated, shows that the 
dissemination of this gene is occurring through at least two different mechanisms. The Tn2 
transposon carrying the ISEcp1-blaCTX-M-15 transposition unit was also able to form a large 
plasmid-mediated MDR region in one isolate, which underlines the versatile role that this 
mobile genetic element has played in the dissemination of CIA resistance in this group of 
isolates. 
Other CTX-M type ESBL genes that were found included blaCTX-M-14 and blaCTX-M-27. The two 
isolates carrying blaCTX-M-27 were from the same feral pigeon. Therefore there is no evidence that 
this ESBL gene has spread to any isolates colonising other birds in the same population. The 
two isolates carrying blaCTX-M-14 were from two different birds; one penguin and one pigeon. 
Both isolates had the same MLST (ST695) and contained the ESBL gene on a plasmid with 
ISEcp1 upstream. Based on this finding, it is possible that a related clone had been passed 
between the two different birds.  
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4.2.2 Resistance against macrolides 
Resistance to macrolides mediated by the composite transposon flanked with IS26 was found in 
its entirety in 20% (4/20) of the penguin and pigeon E. coli isolates from Penguin Island (Figure 
12). One isolate appeared to contain the composite transposon with the class 1 integron lacking 
the two gene cassettes conferring resistance to aminoglycosides and trimethoprim, while several 
others contained the composite transposon without the Tnchr sequence (Figure 12). This finding 
would ideally be validated using PCR to detect the presence of the composite transposon given 
that sequencing error, and de novo assembly error may have a role in the incomplete 
characterisation of this composite transposon in some isolates. However, time constraints 
prevented this from being conducted. Additionally, having phenotypic AMR data for 
azithromycin resistance would have allowed the relationship between genotypic and phenotypic 
AMR to have been further explored. 
All isolates that contained the dfrA17 gene cassette were phenotypically resistant to 
sulfamethoxazole and trimethoprim, while others that did not contain the gene cassette also 
presented with this phenotype. Presence of trimethoprim resistance and sulfamethoxazole 
resistance genes commonly occurred throughout the isolates outside of the composite 
transposon containing the macrolide phosphotransferase cluster. Additionally, presence of the 
aadA5 gene cassette was not strongly associated with phenotypic resistance to gentamycin or 
streptomycin, with many isolates harbouring the gene cassette being sensitive to gentamycin 
and some isolates containing the gene cassette being sensitive to streptomycin. This suggested 
that while the composite transposon had a significant role in the dissemination of macrolide 
resistance genes, it may have had a less critical role in the spread of resistance against folate 
pathway inhibitors and aminoglycosides.  
Gram-negative rods have been widely reported to have natural resistance to macrolides. 
Therefore carriage of the macrolide phosphotransferase cluster in E. coli has historically been 
considered clinically insignificant.130 Despite this, azithromycin is increasingly used as a 
treatment for infection with Enterobacteriaceae, particularly for cases of shigellosis, typhoid 
fever and infection with enterohaemorrhagic E. coli.28 In more recent years, the role of E. coli as 
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a reservoir for macrolide resistance genes has become a cause for concern, with plasmid-
mediated genes having the ability to be passed on to other genera.131 For this reason, the 
presence of the composite transposon throughout so many of the penguin and pigeon E. coli 
isolates may present a public health concern. 
4.2.3 Resistance against fluoroquinolones 
Throughout the E. coli isolates from Penguin Island, there was a low frequency of PMQR 
genes, and a high frequency of SNPs in QRDRs suggesting that the mutations in the QRDRs of 
gyrA, gyrB, parC, and parE were mainly responsible for the high levels of ciprofloxacin 
resistance observed in these isolates (Figure 14). Some of these mutations were more strongly 
associated with phenotypic resistance to fluoroquinolones than others, such as the C248T 
substitution and the A2034C/T SNP in gyrA, the C555A/G mutation in gyrB and the A406G 
SNP in parE. In comparison, the G259A substitution in gyrA was found in less than half of 
isolates that were phenotypically resistant to ciprofloxacin. A recent study investigating the 
causal role of gyrA mutations in quinolone resistance found that point mutations in position 248 
would cause quinolone resistance in previously susceptible E. coli strains.132 Older studies have 
found that a mutation in the amino acid 83 (serine to tryptophan/leucine) in DNA gyrase subunit 
A, which corresponds to the SNP in position 248 of gyrA, can cause quinolone resistance on its 
own.133 In this study, the only mutation that was present in all phenotypically ciprofloxacin-
resistant isolates and absent from all ciprofloxacin susceptible isolates was the C248T 
substitution, which falls in line with the previous literature on mutations in gyrA. Additionally, 
fluoroquinolone resistance as a result of QRDR mutations was observed across ten different 
MLSTs (Figure 14). This is not indicative of a single successful clone but may potentially 
indicate low-level exposure to environmental sources of ciprofloxacin that has influenced the 
accumulation of these mutations in many separate cases. 
PMQRs were only found in a minority of isolates from this study, with qnr found in four 
isolates that were phenotypically resistant to ciprofloxacin and in one that was not. aac(6’)-Ib 
was only found in one isolate chromosomally as part of a large AMR island, more specifically 
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inside a composite transposon-mediated by IS26 (Figure 15). This further indicates that 
horizontal gene transfer may not have had a major role in the high frequency of fluoroquinolone 
resistance observed. 
4.2.4 Third-generation sequencing technologies in AMR research 
This study aimed to detect the mobile genetic elements responsible for the dissemination of 
AMR throughout a group of avian-origin E. coli isolates from Penguin Island, Western 
Australia using whole-genome sequencing technologies. Using de Bruijn graphs for assembly of 
short, second-generation sequencing reads can successfully assemble most prokaryotic genes, 
despite not being able to assemble full genomes.134 Genes that cannot be reconstructed with 
short reads and de Bruijn graphs are heavily related to mobile genetic elements such as 
transposons and IS elements.134 To overcome this limitation of second-generation sequencing 
technologies, the Oxford Nanopore MinION was used to sequence a subset of isolates in an 
attempt to characterise some of the mobile genetic elements detected. Out of the five isolates 
selected for third-generation sequencing, only two produced enough data for hybrid assembly. 
Despite optimising the bioinformatics pipeline used to assemble the Oxford Nanopore MinION 
data, only one of these isolates was able to be fully characterised. 
The combined data from the Illumina sequencing run and the Oxford Nanopore run was able to 
characterise complete mobile genetic elements which could not be achieved solely with Illumina 
sequencing. Across all avian-origin E. coli isolates sequenced with the Illumina NextSeq, IS26 
was present 80 times partially and only once in its entirety (data not shown), indicating that the 
IS26 elements presented as a major obstacle for de Bruijn graph assembly of Illumina reads. As 
a result, characterisation of the composite transposon conferring resistance to macrolides, 
aminoglycosides and folate pathway inhibitors would not have been possible with Illumina 
sequencing alone (Figure 12). 
Despite the benefits of using a combination of second and third-generation sequencing 
technologies, there were many practical limitations associated with Oxford Nanopore MinION. 
Upon receipt, the Oxford Nanopore MinION flow cell was already partially degraded which 
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reduced the data yield available from the sequencing run. Additionally, using the MagMAX™ 
DNA Multi-Sample Kit for DNA extraction may have been suboptimal for ensuring that large 
DNA fragments were recovered. Degradation of the flow cell during shipping may be 
unavoidable, though an alternate DNA extraction protocol should be considered to increase the 
data yield and quality of an Oxford Nanopore MinION sequencing run in the future. 
4.2.5 Conclusions and future directions 
This study has established a bioinformatics pipeline to rapidly detect AMR-associated mobile 
genetic elements in second and third-generation sequencing datasets from Enterobacteriaceae 
isolates, which can be applied to future AMR surveillance projects.  This study has also 
provided a methodological justification to use the Nextera Flex library preparation kit when 
sequencing antimicrobial resistant isolates if coverage bias is a major concern. It must be noted 
that despite Nextera XT producing libraries with more coverage bias, this did not hinder the 
quality of de novo assembly or accuracy of AMR gene detection downstream. The 
improvements to sequencing coverage observed with the Nextera Flex library preparation kit 
appeared unrelated to GC content, however this cannot be confirmed without having included 
organisms with both very low and very high genomic GC content. Additionally, the 
transposomes used in both the Nextera Flex and the Nextera XT library preparation kits 
appeared to be either very similar or identical, though a publication released by Illumina Inc. 
claimed that the improvement to sequencing coverage is a direct result of the transposomes 
being adhered to beads in the Nextera Flex library preparation kit.116 This claim cannot be 
disputed without access to information on the modifications to the transposome which is a 
limitation of this study. A possible cause for this improvement would be the more consistent 
fragment lengths produced by the Nextera Flex library preparation kit which may have had the 
downstream effect of less DNA loss during the bead clean-up stages and more efficient cluster 
generation before the sequencing by synthesis reaction. Ultimately, the exact cause for the 
improvement observed in the Nextera Flex library preparation kit is unknown. 
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Possible future directions for the library preparation kit comparison may include investigation 
of low coverage regions to determine whether any sequence motifs were inherently difficult to 
sequence, for example, if these regions had extreme GC content or highly repetitive regions; 
both of which are notoriously difficult to sequence using Illumina chemistry.69, 82, 117, 119, 120 
Additionally, if this study was repeated with a more diverse set of genera with both extremely 
high and extremely low genomic GC content were included, more sound conclusions could be 
made in regards to the role of GC content related bias. While the issues associated with the 
Nextera XT library preparation kit can be partially circumvented by increasing the concentration 
of DNA applied to the flow cell, the Nextera Flex library preparation kit may be more forgiving 
where mean coverage is low and allow more samples to be pooled and sequenced on the same 
run without sacrificing sequencing quality.  
The high levels of resistance against fluoroquinolones observed in the avian-origin isolates in 
this study is more likely attributed to mutation than the presence of mobile genetic elements, 
however horizontal gene transfer has played a significant role in the resistance against extended-
spectrum cephalosporins observed. While this study was able to characterise mobile genetic 
elements from second and third-generation whole genome sequencing data, the sample size was 
insufficient to make population-level inferences about AMR carriage and horizontal gene 
transfer. A longitudinal study of a larger and representative group of birds in the same 
population will be performed in the future to explain the emergence and movement of AMR 
throughout the avian population on Penguin Island. 
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Appendix I 
Sample information, including phenotypic resistance profiles determined by Shewli Mukerji through disc diffusion tests using Ampicillin (AMP), Ciprofloxacin (CIP), Imipenem 
(IPM), Meropenem (MEM), Sulfamethoxazole + Trimethoprim (SXT), Tetracycline (TET), Gentamicin (CN), Ceftriaxone (CRO), Streptomycin (S), Cefoxitin (FOX), Amoxicillin 
+ Clavulanate (AMC) and Chloramphenicol (C). Resistance profiles are stated as either "R" for resistant, "S" for sensitive and "I" for intermediate. 
Sample ID Source Isolated organism Phenotypic AMR information 
   AMP CIP IPM MEM SXT TET CN CRO S FOX AMC C 
FP 202 CIPA Feral Pigeon E. coli R R S S R R S R R S S S 
FP 209 CIPA Feral Pigeon E. coli R R S S R R S S I S I R 
FP 219 CIPA Feral Pigeon E. coli I R S S R S S S R S I R 
FP 222 CIPA Feral Pigeon E. coli R I S S R R S S R S S R 
FP 225 CIPA Feral Pigeon E. coli R R S S R R S R R S S S 
FP 202 ESBA Feral Pigeon E. coli R R S S R R S R R S S S 
FP 209 ESBA Feral Pigeon E. coli R S S S S R S R R S S S 
FP 219 ESBA Feral Pigeon E. coli R I S S S S S R S S S S 
73 
 
FP 222 ESBA Feral Pigeon E. coli R S S S S S S R S S S S 
FP 225 ESBA Feral Pigeon E. coli R R S S R R S R R S S S 
LP 143 CIPA Little Penguin E. coli R R S S S R S R S S I S 
LP 143 ESBA Little Penguin E. coli R R S S S R S R S S I S 
LP 233 CIPA Little Penguin E. coli R R S S S S S S S S S S 
LP 233 CIPB Little Penguin E. coli I R S S I R R R R S S S 
LP 239 CIPA Little Penguin E. coli R R S S R R S S R S I R 
LP 233 ESBA Little Penguin E. coli R S S S S S S R S S S S 
LP 251 CIPA Little Penguin E. coli R R S S S R R S R S S S 
LP 249 ESBA Little Penguin E. coli R S S S R S S R S S S S 
LP 250 ESBA Little Penguin E. coli R S S S R S S R S S S S 
LP 251 ESBA Little Penguin E. coli R R S S R R R R I I R R 
SA 2 Cat S. enterica Typhimurium str. MU1 R I S S R R R I R R R R 
SA 152 Pig E. coli str. 6/14/6b R S S S R R I S R S S S 
SA 1023 Human S. aureus str. JKD6159 S S S S S S S S S S S S 
SA 1024 Horse S. aureus str. SVH7513 S S S S R I R I S S S S 
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Appendix II 
An overview and comparison of the Nextera XT and Nextera Flex library preparation kits 
 
5 µL neutralise tagment buffer was added 
to each sample immediately 
Samples were incubated at room 
temperature for 5 minutes 
10 µL tagmentation stop buffer was added 
to each sample immediately 
Samples were incubated in a thermal cycler set to 
37oC for 15 minutes, then placed on a magnetic 
stand for 3 minutes  
Supernatant was discarded, then the remaining 
beads were washed twice with tagmentation 
wash buffer 
10 µL tagment DNA buffer was added to 24 
wells of a 96 well plate 
5 µL of diluted genomic DNA was added to 
each well containing tagment DNA buffer 
5 µL amplicon tagment mix was added to each 
sample 
 
Samples were placed on thermal cycler set 
to 55oC for 5 minutes 
Tagmentation master mix was prepared using 
265 µL bead linked transposomes and 265 µL 
tagmentation buffer 
20 µL tagmentation master mix was added to 
each sample 
Samples were placed on thermal cycler set 
to 55oC for 15 minutes 
Tagment Genomic DNA 
Undiluted genomic DNA was added to a 96 well 
plate, with volume of DNA roughly adjusted 
based on concentration 
Total volume of DNA was made up to 30 µL 
using nuclease free water where necessary 
 
Nextera XT Nextera Flex 
Genomic DNA from each isolate was 
diluted to precisely 0.2 ng µL with 
nuclease free water 
75 
 
5 µL of both Index 1 (i7) and Index 2 (i5) 
adapters were added to each sample to 
provide each sample with a unique barcode 
PCR amplification was performed at a 
reaction volume of 50 µL 
Initial denaturation occurred at 72oC for 3 
minutes, then 95oC for 30 seconds 
Samples underwent 12 cycles of PCR at 95oC for 10 
seconds, 55oC for 30 seconds and 72oC for 30 
seconds 
Samples were held at 72oC for 5 minutes for final 
extension, then at 10oC to stop the reaction 
5 µL of i7 adapters and 5 µL of i5 adapters 
were added to each sample, each sample 
receiving a unique combination of adapters 
PCR amplification was performed at a 
reaction volume of 105 µL 
Samples were held at 68oC for 3 minutes and 
98oC for 3 minutes for initial denaturation 
Samples underwent 5 cycles of PCR at 98oC for 45 
seconds, 62oC for 30 seconds and 68oC for 2 
minutes 
Samples were held at 68oC for 1 minute for final 
extension, then at 10oC to stop the reaction 
Amplify Tagmented Genomic DNA 
PCR master mix was prepared with 530 µL 
enhanced PCR mix and 530 µL nuclease free 
water 
40 µL PCR master mix was added to each sample 
Sample plate was sealed and placed on a plate 
shaker set to 1600 RPM for 1 minute 
15 µL of Nextera PCR Master Mix was 
added to each sample 
Clean Up Libraries 
Sample plate was placed on a magnetic stand and 
45 µL supernatant was transferred to a midi plate 
50 µL PCR product for each sample was transferred 
to the corresponding wells of a new midi plate 
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30 µL AMPure XP beads was added to each 
library 
Plate was sealed and placed on a plate 
shaker for 2 minutes at 1200 RPM 
Samples were incubated at room 
temperature for 5 minutes 
 
Samples were placed on a magnetic 
stand for 2 minutes, then supernatant 
was discarded 
1125 µL sample purification beads were 
diluted with 1 mL nuclease free water 
85 µL diluted beads were added to each 
library 
 
Plate was sealed and placed on a plate 
shaker for 1 minute at 1200 RPM 
Samples were incubated for 5 minutes at 
room temperature 
Beads were washed twice using 200 µL 80% 
ethanol, and airdried for 15 minutes 
52.5 µL resuspension buffer was added to each 
sample, then plate was placed on plate shaker for 2 
minutes at 1200 RPM 
15 µL undiluted sample purification beads was 
added to each corresponding well of a second midi 
plate 
The first midi plate was placed on a magnetic 
stand, then 125 µL supernatant was transferred to 
the second midi plate 
Samples were incubated for 5 minutes at room 
temperature 
The second midi plate was placed on a magnet, 
supernatant was discarded 
 
Samples were placed on a magnetic stand, then all 
supernatant was transferred to PCR plate 
The beads were then washed twice with 200 µL 
80% ethanol, then airdried for 5 minutes 
32 µL resuspension buffer was added to each 
library, then plate was incubated for 2 minutes at 
room temperature 
Plate was placed on magnetic stand, then 30 µL 
supernatant was transferred to PCR plate 
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Pool, Denature and Dilute Libraries 
The size distribution and molarity of each DNA 
library was checked using LabChip GX Touch HT 
Nucleic Acid Analyzer 
The size distribution and molarity of each DNA 
library was checked using LabChip GX Touch HT 
Nucleic Acid Analyzer 
Total concentration of each library was 
calculated using Qubit™ dsDNA HS Assay kit 
Total concentration of each library was 
calculated using Qubit™ dsDNA HS Assay kit 
Each library was diluted with resuspension 
buffer to reach a starting concentration of 2 nM 
Each library was diluted with resuspension 
buffer to reach a starting concentration of 2 nM 
10 µL of each diluted library was pooled together 
10 µL of pooled library was added to 10 µL 0.2 N NaOH then incubated for 5 minutes 
10 µL 200 mM Tris-HCl, pH 7 was added to the pooled, denatured library 
HT1 hybridisation buffer was used to dilute the pooled library to 1.3 pM 
Pooled, denatured, diluted library was loaded onto the V2 mid-output 2 x 150 flow cell and 
sequenced using Illumina NextSeq 500 platform 
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Appendix III 
Frequency histograms (left) and bar plots (right) depict the coverage data from bacterial 
chromosomes of each isolate. Data for both Nextera XT and Nextera Flex data are overlayed on 
the same graph, with Nextera XT data shown in blue and Nextera Flex data shown in red. 
Outliers were removed. Graphs show that in most cases, Nextera XT prepared samples had 
more positions of low coverage and more dips in coverage as a result. In samples where mean 
coverage of the Nextera XT prepared sample was much higher, often the Nextera Flex prepared 
sample had better coverage over the dips observed in the Nextera XT sample. 
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Appendix IV 
Frequency histograms (left) and bar plots (right) illustrating the coverage data from plasmids 
from isolates with fully characterised genomes. Data for both Nextera XT and Nextera Flex 
library preparation kits are included on the same graph, with Nextera XT data shown in blue and 
Nextera Flex data shown in red. Across all samples, Nextera XT libraries had more positions of 
low coverage and more dips in coverage than Nextera Flex libraries. 
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Appendix V 
Complete FastQC per sequence GC content metric data. For each isolate, Nextera XT data is 
outlined in blue, and Nextera Flex data is outlined in red. The blue line on the graph represents 
the theoretical distribution of GC content per read, while the red line indicates the actual 
distribution. 
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